Volume 20; Issue supp-S3

Main
European Neuropsychopharmacology
Volume 20; Issue supp-S3

European Neuropsychopharmacology

Volume 20; Issue supp-S3

1

P.2.c.022 Twelve weeks of paroxetine treatment improves prefrontal brain activity. An fMRI study using the Tower of London

H.G. Ruhe, G. van Rooijen, D.J. Veltman, A.H. Schene

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

2

PL.02.01 CSF biomarkers in Alzheimer's disease – use in clinical diagnosis and to monitor treatment effects

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

3

PL.03.01 Epigenetic regulation of cognitive functions

I. Mansuy, K. Koshibu, J. Graeff

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

4

S.01.02 Antidepressants: are effects on emotion their primary mode of action?

S. Murphy, C.J. Harmer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

5

S.01.03 How antidepressants change emotional experience in depressed patients

P. Stein, R. Lanzenberger, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

6

S.01.04 Steroid-monoamine interactions in emotion

R. Hurlemann, O.A. Onur, J. Kukolja

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 56 KB

english, 2010

7

S.01.05 How cortisol affects emotion

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

8

S.02.02 Tauopathy causing frontotemporal lobe degeneration

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

9

S.02.03 Tau toxicity in cell and animal models

E.M. Mandelkow, E. Thies, A. Sydow, Y. Wang, J. Biernat, E. Mandelkow

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

10

S.02.04 Physiopathological features of tauopathies and tau transgenic mice

L. Buée, S. Burnouf, L. Troquier, A. Leboucher, C. Laurent, H. Le Freche, J. Brouillette, M. Hamdane, N. Sergeant, D. Blum

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

11

S.02.05 Genetics of tauopathies

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

12

S.03.01 The past, present and future role of the dopamine D2 receptor in schizophrenia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

13

S.03.02 Searching for an optimised pharmacological cocktail: focus on antipsychotics with combined D2 and serotonin 5-HT1A activity

A. Newman-Tancredi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

14

S.03.03 Brain connectivity modulation by novel antipsychotics: an electrophysiological approach

M. Spedding, C. Sebban, T. Jay, E. Schenker, I. Gacsalyi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

15

S.03.04 An alternative approach to antipsychotic activity: the metabotropic glutamatergic receptor

A. Weizman, A. Krivoy, T. Fischel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

16

S.03.05 The muscarinic receptor family: potential targets for the treatment of symptoms associated with schizophrenia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

17

S.04.01 Identification of a mouse febrile seizure susceptibility gene

E.V.S. Hessel, M. de Wit, I.G. Wolterink-Donselaar, H.A. van Lith, M.J.H. Kas, P.N.E. de Graan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

18

S.04.02 Lack of central serotonin synthesis: effects on development of GABAergic subpopulations

J. Waider, L. Gutknecht, K.P. Lesch

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

19

S.04.03 Inositol monophosphatase: drug target or false alarm?

N. Singh, S. Vasudevan, J. Thomas, O. Kuznetsova, M. Knight, P. Aley, T. Sharp, G. Churchill

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

20

S.04.04 Stress-induced alterations in hippocampal and amygdalar microRNAs: effects of lithium

R.M. O'Connor, O.F. O'Leary, A. Dinan, A. Gokul, T.G. Dinan, J.F. Cryan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

21

S.04.05 Interactions of oligomeric and fibrillar b-amyloid with a7 neuronal nicotinic receptors and synaptic targets in Alzheimer's disease

A. Lilja, O. Porras, E. Storelli, A. Nordberg, A. Marutle

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

22

S.04.06 Altered aggressive behaviour following genetic and pharmacological manipulation of serotonin autoinhibition

E. Audero, B. Mlinar, Z. Skachokova, R. Corradetti, C. Gross

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

23

S.04.07 Behavioural and neurochemical consequences of 5-HT transporter deletion on 5-HT2C receptor functions in mice

C.B.P. Martin, C. Chevarin, K.P. Lesch, M. Hamon, L. Lanfumey, R. Mongeau

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

24

S.04.08 Impulsive decision making predicts resistance to extinction of cocaine seeking and enhanced vulnerability to cue-induced relapse

N. Broos, A.N.M. Schoffelmeer, L. Diergaarde, T. Pattij, T.J. De Vries

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

25

S.05.02 Neuronal signaling and epigenetic mechanisms at the cognition-emotion interface

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

26

S.05.03 The role of endocannabinoids in the amygdala in the regulation of emotional memory

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

27

S.05.04 Glucocorticoids and noradrenaline in severe stress exposure in humans

G. Schelling, B. Roozendaal, P. Campolongo, D. de Quervain

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

28

S.05.05 D-cycloserine and exposure therapy

B. Rothbaum, M. Davis, K. Ressler

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

29

S.06.02 Can we explain the epidemiology of schizophrenia in terms of the pathology of striatal dopamine?

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

30

S.06.04 NGF and BDNF as neuroendocrine factors involved in the response to early life stress and susceptibility to psychopathology: evidence from animal models

F. Cirulli, L. Aloe, N. Francia, A. Berry, E. Alleva, S.J. Suomi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

31

S.06.05 Presentation of a large European collaborative study of environmental risk factors for psychosis – the EU GEI environmental work-package

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

32

S.07.01 Role of Cdk5 activators in psychiatric diseases, learning and memory

O. Engmann, T. Hortobagyi, D. Bannerman, A.J. Thompson, K.P. Giese

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

33

S.07.02 Cued but not contextual fear conditioning impairment in the NMDA receptor subunit NR1-DbhCre transgenic mice

W. Solecki, K. Szklarczyk, J. Kubik, M. Sikora, J. Parkitna, R. Przewlocki

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

34

S.07.03 Antidepressant treatment modulates neural responses to self-referential words in subjects with high neuroticism

M. Di Simplicio, R. Norbury, C.J. Harmer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

35

S.07.04 CYP2D6 genotype predicts antidepressant dose in the GENDEP project

R. Keers, M. Ingelman-Sundberg, J. Hauser, W. Maier, M. Rietschel, O. Mors, P. McGuffin, A.E. Farmer, I.W. Craig, K.J. Aitchison

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

36

S.07.05 Abnormalities in reward prediction error signals in depression and schizophrenia

V. Gradin, P. Kumar, G. Waiter, T. Ahearn, I. Reid, C. Stickle, M. Milders, J. Hall, J.D. Steele

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

37

S.07.06 Netrin G1 polymorphisms in cocaine and alcohol codependence vulnerability: from mice to men

S. Kelai, G. Maussion, N. Munoz, C. Boni, N. Ramoz, M. Simonneau, P. Gorwood

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

38

S.07.07 Addiction proneness: contribution of the endocannabinoid system and reward processing

H.H. van Hell, G. Jager, A. Brouwer, M.G. Bossong, R.S. Kahn, N.F. Ramsey

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

39

S.07.08 Differential response to treatment across countries in a randomized clinical trial in mania

I. Pacchiarotti, E. Pappadopulos, F.S. Mandel, I. Lombardo, A. Loebel, E. Vieta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

40

S.08.01 Involvement of hippocampal neurogenesis in the control of the HPA axis: evidence from animal models of affective disease

C. Belzung, A. Surget, A. Tanti, A. Laugeray, Q. Rainer, G. Griebel, R. Hen, C. Touma, P. Ruppert

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

41

S.08.02 Chronic stress, depressive disorders and obesity: insights from animal models

A. Bartolomucci, V. Sanghez, C. Cero, V. Carola, C. Gross, A. Vidal-Puig, Z. Zukowska, S. Parmigiani, P. Palanza

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

42

S.08.03 Early life stress in rodents as predictor for structural and functional neuroplasticity later in life

M. Joëls, F. Van Hasselt, H. Krugers

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 54 KB

english, 2010

43

S.08.04 Restoring normal synaptic function in frontal netwoks as a new approach to treat mood disorders

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

44

S.08.05 New findings on the neurobiology of resilience and susceptibility to social stress

A.J. Eisch, D.C. Lagace, M.H. Donovan, N.A. DeCarolis, L.A. Farnbauch, S. Malhotra, O. Berton, E.J. Nestler, V. Krishnan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

45

S.09.01 Whole-brain structural MRI of autism-associated neuroanatomical features

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

46

S.09.02 Environment and vulnerable physiology in autism

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

47

S.09.03 Neurotrophic factors in autism

R. Riikonen, I. Makkonen, J. Kuikka, W. Kaufmann, U. Turpeinen, R. Vanhala, H. Kokki

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

48

S.09.04 Mechanisms controlling the development of cortical interneurons: potential implications for Autism Spectrum Disorders

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

49

S.09.05 Neurobiological treatment of autism spectrum disorders: present and future

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

50

S.10.01 Biological pathways underpinning chronic fatigue, somatisation and psychosomatic symptoms

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

51

S.10.02 Neurobiological links between visceral dysfunction and affective disorders

P. Holzer, E. Painsipp

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

52

S.10.03 Animal models of co-morbid depression and irritable bowel syndrome

J. Cryan, J.A. Bravo, G. Clarke, N.P. Hyland, D. O'Malley, D. O'Mahony, M. Julio-Pieper, D.P. McKernan, M. Tramullas, T.G. Dinan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

53

S.10.04 Ghrelin, leptin and other neurohormones involved in concerted regulation of brain and visceral functions

J. Epelbaum, M.C. Bourdel, R. Dardennes, B. Estour, B. Galusca, N. Germain, P.H. Gorwood, D. Grouselle, J.P. Olié, A. Pham-Scottez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

54

S.10.05 Brain imaging in patients with gastrointestinal disorders

E.A. Mayer, J. Labus, K. Tillisch

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

55

S.12.01 Physiological and therapeutic relevance of constitutive activity at 5-HT2C receptors

U. Spampinato, A. Cathala, G.M. Leggio, M. Neny, F. Rouge-Pont, F. Drago, P.V. Piazza

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

56

S.12.03 Antidepressant-induced functional adaptive changes in 5-HT2C receptors: are they underlying their anxiolytic effects?

R. Mongeau, C.B.P. Martin, C. Chevarin, R. Maldonado, M. Hamon, P. Robledo, L. Lanfumey

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

57

S.12.04 5-HT2C receptors and drug addiction

M. Filip, M. Zaniewska, A.C. McCreary

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

58

S.12.05 5-HT2C receptor ligands in the treatment of obesity and type 2 diabetes

L.K. Heisler, D.D. Lam

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

59

S.14.01 Shared and specific vulnerability in substance abuse

N. Ramoz, Y. Le Strat, P. Gorwood

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

60

S.14.02 Glutamatergic mechanisms in alcohol addiction

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

61

S.14.03 Predictors of relapse in alcohol dependence

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

62

S.14.04 Role of glucocorticoids in alcoholism

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

63

S.14.05 Place for baclofen in treating alcoholism

G. Colombo, P. Maccioni, M.A.M. Carai, G.L. Gessa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

64

S.15.01 Data mining and neuroinformatics

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

65

S.15.02 Modulation of dysregulated protein-protein-interactions in Huntington's disease

E.E. Wanker, M. Strödicke

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

66

S.15.03 microRNA networks and neurodegenerative disease

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

67

S.15.04 Systems biology approaches to study Parkinson's disease in C. elegans models

G. Wong, M. Lakso, S. Asikainen, S. Vartiainen, L. Heikkinen, R. Nass

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

68

S.15.05 Network-based data integration for modifier gene and drug target discovery in Huntington's disease

C. Néri, C. Bicep, L. Mesrob

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

69

S.16.01 Potential therapeutic targets from cellular/molecular signalling mechanisms in depression models

P. Svenningsson, T.M. Eriksson, K. Björk, S.O. Ögren, A. Mathe, M. El Yacoubi, J.M. Vaugeois

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

70

S.16.02 Targeting mechanisms of two differentially targeted serotonin receptors: dendritic 5-HT1A versus axonal 5-HT1B receptors

M. Darmon, S. Al Awabdh, J. Masson, M.B. Emerit

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

71

S.16.03 PPARgamma as drug target for neurological and psychiatric diseases

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

72

S.16.04 Formation of N-acylethanolamines in the brain: where and when?

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

73

S.16.05 N-acylethanolamines and motivated behaviour: focus on appetite disorders and alcoholism

F. Rodríguez de Fonseca, A. Bilbao

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

74

S.17.01 Circadian rhythms: their role and dysfunction in affective disorder

A. Wirz-Justice

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

75

S.17.02 Translating molecular circadian findings into animal behaviour

H. Einat, N. Kronfeld-Schor

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

76

S.17.03 Pharmacological therapies of affective disorders influencing circadian rhythms

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

77

S.17.04 Phase changes as correlates of clinical antidepressant response

F. Benedetti, S. Dallaspezia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

78

S.17.05 Can targeting circadian rhythym lead to better treatments for mood disorders?

C.H. Large, J. Huxley-Jones

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

79

S.18.02 Genetics of anorexia nervosa

D.A. Collier, C.M. Bulik, P.F. Sullivan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

80

S.18.03 Genetics of obesity

J. Hebebrand, A. Hinney, A. Scherag

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

81

S.18.05 Neurobiological mechanisms of hyperactivity in anorexia nervosa

R.A.H. Adan, L.A.W. Verhagen, S.L. Dickson, E. Egecioglu, R.J. DiLeone

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

82

S.19.01 Cerebral correlates of pain and depression

K.J. Bär, J. Terhaar, G. Wagner, M.K. Boettger

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

83

S.19.02 Emotional behaviour and pain in animal models

C. Becker, C. Rivat, A. Blugeot, B. Zeau, J.J. Benoliel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

84

S.19.03 Neurobiology of fear-induced analgesia

D.P. Finn, M. Roche, G.K. Ford, K. Rea, W.M. Olango, R.K. Butler, B. Harhen, S.M. Geranton, S.P. Hunt

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

85

S.19.04 Altered pain processing in posttraumatic stress disorder

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

86

S.19.05 Affective and cognitive aspects of pain processing in borderline personality disorder

C. Schmahl, I. Niedtfeld, I. Klossika

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

87

S.20.01 Nicotinic receptors and the modulation of transmitter release in the prefrontal cortex

S. Wonnacott, P.D. Livingstone

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

88

S.20.02 Alpha7 nicotinic receptors and synaptic plasticity

H.D. Mansvelder, R.B. Poorthuis, B. Bloem, K. Guillem

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

89

S.20.03 Nicotinic agonists in animal models of attention and working memory

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

90

S.20.04 Alpha7 signalling pathways and their relevance to cognition

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

91

S.20.05 NIMH/FDA guidelines for clinical trials for cognition in schizophrenia: how much have we advanced?

S. Marder, R.W. Buchanan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

92

S.21.01 Weight gain and antidepressants: a meta-analysis clearly differentiates SSRIs differences

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

93

S.21.02 The weight of the world: the burden and management of antipsychotic induced obesity

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

94

S.21.03 Psychotropic drugs and weight gain: which are the mechanisms?

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

95

S.21.04 Arcuate NPY/AgRP neurons and the control of energy balance

S. Luquet, A. Joly, R. Denis, R. Palmiter, C. Magnan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

96

S.21.05 Antipsychotic-related metabolic and endocrine adverse events in pediatric patients: frequency, monitoring and management strategies

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

97

S.22.02 Alostatic load and oxidative stress in bipolar disorder

F. Kapczinski, K.M. Ceresér, M. Kauer-Sant'Anna

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

98

S.22.03 Neurocognition and psychosocial function in bipolar disorder

O.A. Andreassen, C. Simonsen, K. Sundet

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

99

S.22.04 Predictors of functioning in bipolar disorder

S. Dittmann, F. Seemüller, K. Hennig-Fast, R.R. Engel, M. Riedel, H.C. Grunze, W.E. Severus

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

100

S.22.05 Neurobiological correlates of treatment response to psychoeducation

F. Colom, I. Pacchiarotti, A. Murru, A.M.A. Nivoli, E. Vieta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

101

S.23.01 Risk factors for Alzheimer's disease

H. Soininen, A. Solomon, M. Kivipelto

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

102

S.23.02 Cholinergic imaging with PET

C. Haense, K. Herholz

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

103

S.23.05 The role of the immune system in clearance of Abeta from the brain

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

104

S.24.01 Epigenetic effects on brain function and behaviour

L.S. Wilkinson, A.R. Isles, W. Davies, T. Humby

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

105

S.24.02 Cognitive endophenotypes in schizophrenia

M.F. Aukes, B.Z. Alizadeh, C. Kemner, M.M. Sitskoorn, R.A. Ophoff, R.S. Kahn

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

106

S.24.03 Genotype-phenotype relationships for psychiatric disorders; gender effects

A. Heinz, E. Friedel, F. Schlagenhauf, I. Puls

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

107

S.24.04 Endophenotypes of Disc1 missense mutations in mice

S.J. Clapcote, T.V. Lipina, J.C. Roder

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

108

S.24.05 Transgenic mouse models in addiction research

P. Robledo, E. Martín-García, A. Plaza-Zavala, F. Berrendero, R. Maldonado

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

109

S.25.01 Shared pathogenetic mechanisms of neurodegeneration between MS, stroke and neurodegenerative diseases

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

110

S.25.02 Ion channels and exhangers as potential targets for stroke therapy

L. Annunziato, G. Pignataro, O. Cuomo, P. Molinaro, F. Boscia, A. Scorziello, A. Secondo, A. Pannaccione, R. Sirabella, G.F. Di Renzo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

111

S.25.03 Neuroprotection with minocyclin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

112

S.25.04 Cannabinoids and neuroprotection

J. Ferníndez-Ruiz

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

113

S.25.05 Erythropoietin and neuroprotection

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

114

S.26.01 An innovative animal model of PTSD and its role in translational research

M.A. Matar, J. Zohar, H. Cohen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

115

S.26.02 Brain mechanisms in PTSD

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

116

S.26.03 PTSD and physical illness

C. Spitzer, B. Löwe, S. Barnow, H.J. Grabe

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

117

S.26.04 Molecular neuroscience of PTSD

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

118

S.26.05 Early pharmacological intervention in PTSD: an update

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

119

S.27.01 Pharmacological actions of cannabinoids

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

120

S.27.02 Plant cannabinoids and psychiatric disorders: preclinical findings

D. Parolaro, D. Vigano, E. Zamberletti, C. Guidali, N. Realini, T. Rubino

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

121

S.27.03 The endocannabinoid system in neurodegeneration and psychiatry

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

122

S.27.04 Harmful psychiatric effects of plant cannabinoids in humans

C. Henquet, R. Kuepper, M. Konings, J. Van Os

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

123

S.27.05 Targeted cognitive-behavioral treatment for cannabis use disorders (CANDIS): efficacy, longterm stability, and efficiency

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

124

S.28.01 Pathology of astroglia, GABA interneurons and pyramidal glutamatergic neurons in postmortem prefrontal cortex in major depression: relevance to neuroimaging studies

J.J. Miguel-Hidalgo, G. Rajkowska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

125

S.28.02 Glutamate and the prefrontal cortex in the psychopathology of depression – a combined fMRI-MRS approach

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

126

S.28.03 Abnormalities of glutamate and GABA systems in depression: novel findings from studies using MRS and PET

G. Hasler, A. Deschwanden, B. Karolewicz, F. Buck, S.M. Ametamey, W.C. Drevets, J.W. Van der Veen, J. Shen, V. Treyer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

127

S.28.04 The antidepressant potential of mGluR5 and GABA-B receptor antagonists in rodent models of depression

A. Pilc, A. Palucha-Poniewiera, J. Wieronska, K. Stachowicz, P. Branski, A. Siwek, M. Dybala, G. Nowak

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

128

S.28.05 Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioural deficits by the glutamate-modulating drug riluzole

G. Sanacora, M. Banasr, G. Chowdhury, A. Lepak, K. Behar

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

129

E.01.01 Compulsivity in preclinical research

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

130

E.01.02 Compulsivity across psychiatric disorders

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

131

E.02.01 Psychotropic drugs and pain mechanisms

J.A. Mico, E. Berrocoso

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

132

E.04.01 Electroconvulsive therapy (ECT)

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

133

E.04.02 Clinical predictors and drugs interactions of transcranial magnetic stimulation (TMS)

K.P. Ebmeier, C.L. Allan, L.L. Herrmann

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

134

E.04.03 When should deep brain stimulation (DBS) be considered as a potential treatment for patients with treatment resistant depression?

T. Schläpfer, B. Bewernick, S. Kayser, B. Hadrysiewicz

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

135

E.05.02 Metabolic alterations and their background in patients with affective disorders

K. Kahl, S. Lampen-Inkamp, B. Claassen, T. Peschel, G. Schik

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

136

E.06.01 The stroke patient as a challenge for the psychiatrist

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 32 KB

english, 2010

137

P.1.a.001 Migraine and cardiovascular diseases:role of ACE and MTHFR genes polymorphisms

A. Capasso, A. Bisogno, A. Agresta, V. Pizza

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

138

P.1.a.002 DTNBP1, HSPs and TAAR6 variations influence schizophrenic phenotype and treatment response

C. Pae, A. Drago, A. Serretti

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

139

P.1.a.003 Pharmacogenetic study on metabolic syndrome induced by atypical antipsychotics and mood stabilizers

G. Bondolfi, E. Choong, M. Etter, B. Oneda, H. Tayebi, J.M. Aubry, C.B. Eap

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

140

P.1.a.004 Associations between AVPR1b and NR3C1 gene variants and HPA axis responses to psychosocial stress

D. van West, J. Del-Favero, D. Deboutte, C. Van Broeckhoven, S. Claes

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

141

P.1.a.005 A pilot study for family based association analysis of qualitative and quantitative traits for Korean schizophrenics

B. Lee, D. Kwon, Y. Kim, Y. Chung, J. Park, S. Kim, C. Kang, J. Kim, Y. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

142

P.1.a.006 Association between circadian gene polymorphisms and posttraumatic stress symptoms in Korean young females

K. Choi, E. Joo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

143

P.1.a.007 Neurotrophin family genes (BDNF and NTRK2) and personality traits in healthy individuals

A. Kazantseva, A. Khannanova, T. Traks, S. Koks, E. Khusnutdinova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

144

P.1.a.009 Association study of DISC1 gene with cognitive functions in Korean schizophrenia patients and healthy controls

D. Park, H. Park, T. Park, S. Oh, E. Cho, N. Kim, K. Hong

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

145

P.1.a.010 The role of sigma-1 receptor polymorphism in the pathogenesis of Alzheimer's disease: preliminary results

A. Juhasz, A. Feher, A. Rimanoczy, M. Galfi, J. Kalman, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

146

P.1.a.011 The study of prolactin gene polymophism in schizophrenic patients

J.K. Rybakowski, M. Dmitrzak-Weglarz, P. Kapelski, J. Hauser

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

147

P.1.a.012 Association of aggressive traits with the 5-HTTLPR polymorphism in depressed and healthy women

X. Gonda, K.N. Fountoulakis, J. Lazary, D. Pap, M. Sasvari-Szekely, A. Veres-Szekely, G. Bagdy, G. Faludi, Z. Rihmer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

148

P.1.a.013 In silico analysis of expression of orphan G protein-coupled receptor 155 during inflammation – implications for autism

A.H. Swiergiel, G.R. Juszczak, K.M. Grochowska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 65 KB

english, 2010

149

P.1.a.014 Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in Korean population

D.S. Moon, J.W. Paik, A.R. Cho, J.W. Kim, J.H. Chung, E.J. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

150

P.1.a.016 Biochemical and genomical characteristic of mice lacking the noradrenalin transporter

J. Solich, P. Palach, M. Kusmider, M. Gaska, A. Faron-Gorecka, M. Dziedzicka-Wasylewska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

151

P.1.a.017 Effect of a functional NOS1 promoter polymorphism and life events on personality, anxiety and depressiveness

J. Harro, T. Kurrikoff, A. Reif, E. Kiive, S. Herterich, T. Tulviste, T. Veidebaum, K.P. Lesch

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

152

P.1.a.018 Alzheimer's disease risk and polymorphisms of the DHCR24 gene

A. Feher, A. Juhasz, A. Rimanoczy, J. Kalman, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

153

P.1.a.019 Case-report of Charcot-Marie-Tooth disease in a patient with alcohol dependence

S. Ilut, M. Valcu, V. Vacaras, L. Fodoreanu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

154

P.1.a.020 Expression of calcyon gene in rat brain after stressfull behavioural procedures

M. Kusmider, A. Faron-Gorecka, M. Gaska, P. Gruca, M. Papp, M. Dziedzicka-Wasylewska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

155

P.1.a.021 Effects of desipramine treatment on hippocampal transcriptome in mice differing in responses to antidepressants

P. Lisowski, G.R. Juszczak, J. Goscik, L. Zwierzchowski, M. Wieczorek, A.H. Swiergiel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

156

P.1.a.022 Preliminary study investigating the interferon gamma +874 T/A polymorphism and the somatic type of depression

T. Rimay, G. Daroczi, E. Kovacs, I. Benak, A. Feher, A. Juhasz, A. Vetro, M. Kovacs

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

157

P.1.a.023 Reduced sensitivity to nociceptive stimuli in mutant mice with low glutamatergic tone in the central nervous system

V. Kayser, M. Melfort, J. Masson, M. Hamon, S. Bourgoin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 54 KB

english, 2010

158

P.1.a.024 Brain-derived neurotrophic factor gene polymorphism Val66Met, personality traits and academic success

K. Hiio, J. Parik, H.M. Loit, J. Harro

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 38 KB

english, 2010

159

P.1.a.025 Antipsychotics-induced weight gain and the 5-HT2A and 5-HT6 receptor gene polymorphisms in Korean schizophrenic patients

H.C. Kim, Y.A. Kim, S.W. Jung, D.K. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

160

P.1.b.001 Repetitive transcranial magnetic stimulation (rTMS) in the treatment of neuropatic pain

M. Klirova, J. Fricova, P. Sos, T. Novak, B. Tislerova, M. Haeckel, V. Masopust, R. Rokyta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

161

P.1.b.002 Motor tract white matter correlates with volitional motor behaviour in schizophrenia

S. Walther, H. Horn, A. Federspiel, N. Razavi, T. Dierks, W. Strik, T.J. Müller

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

162

P.1.b.003 The correlation between self-rated stress response and short-term heart rate variability (HRV) in healthy females

J. Woo, T. Kim, J. Dimsdale

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

163

P.1.b.004 White matter microstructural alterations of the extrastriate visual cortex in women with anorexia nervosa

H. Frieling, T. Peschel, J. Fischer, T. Engelhorn, T. Hillemacher, S. Bleich, M. de Zwaan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

164

P.1.b.005 Three dimensional electroencephalographic mapping with eLORETA during sleep onset period

D. Park, C. Shin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

165

P.1.b.006 Detrended fluctuation analysis during sleep onset period

C. Shin, D. Park

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

166

P.1.b.007 Emotional face processing in the 5-HT2A model of altered states of consciousness using event-related potentials

A. Schmidt, P.A. Csomor, R. Bachmann, M. Kometer, F.X. Vollenweider

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

167

P.1.b.008 Post imperative negative variation as an endophenotypic marker of schizophrenia?

P. Castro, P. d'Alcantara, G. Cheron

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

168

P.1.b.009 Effect of cobalt chloride into periaqueductal gray matter on panic reactions organized by the medial hypotalamus

M.A. Castiblanco-Urbina, A. Uribe-Mariño, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

169

P.1.b.010 Skin conductance and electromyographic responses to different auditory stimuli in patients with schizophrenia

V. Bilgic, A. Turkcan, G. Ozgen, S. Akdemir, S. Kara

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

170

P.1.b.011 Thyroid hormones and exposure to violence in childhood in suicide attempters

C. Sinai, A.L. Nordstrom, P. Nordstrom, J. Jokinen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

171

P.1.b.012 High prevalence of human herpesvirus 8 in a tunisian sample of schizophrenic patients

Y. El Kissi, N. Hannachi, S. Samoud, S. Gaabout, M. Ayachi, J. Boukadida, B. Ben Hadj Ali

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

172

P.1.b.013 Characteristics of the power spectrum alpha activity in relation to clinical expression of schizophrenia

N. Manuseva, B. Stefanovski

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

173

P.1.b.014 Deep brain stimulation of the nucleus accumbens for therapy-refractory obsessive-compulsive disorder

D. Denys, M. Mantione, M. Figee, P. van den Munckhof, F. Koerselman, H. Westenberg, R. Schuurman

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

174

P.1.c.001 Acute psychomotor, memory and subjective effects of MDMA and THC (co-) administration over time in healthy volunteers

G. Dumont, J. van Hasselt, M. de Kam, J. van Gerven, D. Touw, J. Buitelaar, R. Verkes

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

175

P.1.c.002 Biological peculiarities of the analgesic drug – nefopam in rats

P. Nowak, M. Beska, R. Szkilnik

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

176

P.1.c.003 Cannabinoid mediated analgesia in rats with a central noradrenergic lesion modeling depressive-like symptoms

E. Korossy-Mruk, R. Brus, R. Szkilnik, P. Nowak

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

177

P.1.c.004 Defensive effects of polyprenol-containing drug ropren in a model of subacute hepatosis with encephalopathy in rats

P.D. Shabanov, V.S. Sultanov, V.I. Roshchin, T.V. Nikitina, A.A. Lebedev, E.R. Bychkov, S.N. Proshin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

178

P.1.c.005 Angiotensin AT1 receptor blockade prevents memory impairment caused by chronic stress

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

179

P.1.c.006 Delayed effects of NR2B subunit-specific antagonist Ro 25–6981 on spatial memory in adult rats

O.A. Solovieva, A.T. Proshin, Z.I. Storozheva, V.V. Sherstnev

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

180

P.1.c.007 Effects of selective glutamate mGlu5 receptor antagonist, MPEP, on sleep and wakefulness in the rat

G.L. Scesa, M. Cavas, J.F. Navarro

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

181

P.1.c.008 Schizophrenia and neuroactive steroids in males

M. Bicikova, M. Hill, D. Ripova, P. Mohr, R. Hampl

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

182

P.1.c.009 Role of the norepinephrine uptake transporter in the mechanism of action of MDMA (Ecstasy)

C.M. Hysek, M. Ineichen, V.G. Nicola, L. Simmler, M.E. Liechti

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

183

P.1.c.010 Lithium reduces neuropathic pain: involvement of opioid system

H.r. Banafshe, G. Hamidi, A. Mesdaghinia, M. Noorani Arani, M. Honarkar Ramezani

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

184

P.1.c.011 Influence of the structural analogue of AVP(6–9) on training of rats followed with positive and negative reinforcement

A. Belyakova, O.G. Voskresenskaya

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

185

P.1.c.012 Design, structural characterisation and biocompatibility evaluation of tramadol loaded nanoparticulate systems

L. Tartau, A. Garlea, V. Melnig

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

186

P.1.c.013 A7 nicotinic receptor agonist enhances neurogenesis and reduces brain inflammation after lipopolysaccharide (LPS) or radiation treatment

W. Zhao, S.M. Toler, P.M. Lippiello, M. Bencherif

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

187

P.1.c.014 MBDB, a recreational drug similar to MDMA, exhibits anxiogenic-like effects in mice tested in the elevated plus-maze

A.t. Muela, M. Martin-Lopez, M. Cavas, J.f. Navarro

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

188

P.1.c.015 Effects of AMN082, an allosteric positive modulator of presynaptic mGluR7 activity, on sleep-wake states in rats

G. Scesa, M. Cavas, J.F. Navarro

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

189

P.1.c.016 Opposing roles of CB1 and TRPV1 in panic-like responses mediated by dorsal periaqueductal gray

A. Terzian, P. Casarotto, D.C. Aguiar, H. Zangrossi Jr., F.S. Guimarães, C.T. Wotjak, F.A. Moreira

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

190

P.1.c.017 New pathway involved in the alteration of reflex bradycardia in response to stress: study in rats and mice

C. Sevoz-Couche, F. Netzer, J.F. Bernard, M. Hamon, J.J. Benoliel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

191

P.1.c.018 Increased serotonin 2c receptor editing in a mouse model of obesity

H. Schellekens, T.G. Dinan, J.F. Cryan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

192

P.1.c.019 Effects of diazepam on contextual serial memory and hippocampal corticosterone in stressed middle-aged mice

C. Tronche, D. Beracochea, P. Liscia, M. Coutan, C. Pierard

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

193

P.1.c.020 Effect of mycophenolate mofetil on behavioural and neuroimaging outcomes in transient focal cerebral ischemia in rats

A. Chauhan, K.H. Reeta, Y.K. Gupta, S.K. Mewar, U. Sharma, N.R. Jagannathan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

194

P.1.c.021 Protective effect of Anacyclus pyrethrum against seizures and seizure-induced cognitive impairment in rats

M. Pahuja, J. Mehla, K.H. Reeta, S. Joshi, Y.K. Gupta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

195

P.1.c.022 Involvement of opioid and GABA receptors in the antinociceptive effect of tianeptine in mice

R. Suciu, A.C. Suciu, D. Patrascu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

196

P.1.c.023 Assessment of benzodiazepines-valproic acid pharmacokinetic interaction in adult epileptic patients: population approach

K. Vucicevic, B. Miljkovic, M. Pokrajac, M. Prostran, Z. Martinovic, R. Velickovic, I. Grabnar

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

197

P.1.c.024 A study of the effect of lamotrigine on two convulsive tests in mice

D. Getova, A. Mihaylova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

198

P.1.c.025 Longterm safety and efficacy outcomes in adults with ADHD treated with prolonged-release methylphenidate

B. Schaeuble, M. Hofecker, J. Buitelaar, S. Kooij, J. Dejonckheere, S. Waechter

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

199

P.1.c.026 Delayed effects of nociceptin analogue administration to anxiety and learning in juvenile rats

E.A. Ivanova, A.V. Malyshev, N.Y. Sarycheva, V.A. Dubynin, V.N. Kalikhevich, Z.A. Ardemasova, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

200

P.1.c.027 Glucocorticoid receptors selectively modulate stress-evoked dopamine release in the prefrontal cortex

K. Butts, G. Vacca, S. Ahn, J. Weinberg, A.G. Phillips, A.H. Young

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

201

P.1.c.028 The effects of atypical antipsychotic drugs on regulation of cell cycle against MPP+-induced apoptosis in PC12 cells

Y.H. Kim, H.Y. Cho, S.W. Park, J.G. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

202

P.1.c.029 Effects of pregabalin and topiramate on impulsivity and certain impulsive-related behaviors

F. Navarrete, J.M. Pérez-Ortiz, J. Manzanares

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

203

P.1.c.030 Second messengers in obsessive-compulsive disorder: role of adenylate-cyclase

D. Marazziti, S. Baroni, G. Consoli, M. Catena Dell'Osso, G. Giannaccini

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

204

P.1.c.031 Effect of almorexant treatment on sleep variables in patients with primary insomnia compared with healthy controls

G. Dorffner, P. Anderer, B. Saletu, G.M. Saletu-Zyhlarz, H. Danker-Hopfe, J. Black, J. Dingemanse, P. Hoever

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

205

P.1.c.032 Interaction study between almorexant, a dual orexin receptor antagonist, and desipramine in healthy male subjects

H. Cruz, P. Hoever, J. Hay, F. Alessi, J. Dingemanse, J. van Gerven

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

206

P.1.c.033 Effect of once-daily almorexant treatment for 6 weeks on the sleep-wake cycle of normal Wistar rats

C. Brisbare-Roch, C. Fischer, F. Jenck

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

207

P.1.c.034 Dorsal raphe nucleus a1, a2 and beta; noradrenergic receptors modulate panic reactions organised by the medial hypothalamus

A. Uribe-Mariño, M.A. Castiblanco-Urbina, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

208

P.1.c.035 Role of 5-HT1A receptor on innate fear behavioural attentuation by cannabidiol in a prey versus predator paradigm

A. Uribe-Mariño, A. Francisco, M.A. Castiblanco-Urbina, A. Twardowschy, C.J. Salgado-Rohner, J.A.S. Crippa, J.E.C. Hallak, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

209

P.1.c.036 Nitric oxide modulation of memantine-induced deficits in sensorimotor gating in rats

C. Salum, N.F. Henriques-Santos, M.C. Brosco, E.A. DelBel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

210

P.1.c.037 The profile of attentional deficits in schizophrenia: implications for pharmacotherapy

K.A. Wesnes, H. Brooker, C.J. Edgar, H. Hassman

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

211

P.1.c.038 Psychopharmacological treatment of borderline personality disorder

R. Manzanero, I. Duran, M. Garcia, A. Chinchilla, A. Cebollada, M. Vega, A. Soto

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

212

P.1.c.039 Risperidone-induced hyperprolactinemia: reversal by aripiprazole

E. Esteban, G. Gomez, L. Pereyra, A. Mont

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

213

P.1.c.040 Impulsive aggression in a patient treated with levetiracetam

J.L. Villegas Martinez, J.A. Blanco Garrote, P. Marques Cabezas, G. Cabus Piñol, J. Coullaut García

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

214

P.1.c.041 Interaction study between almorexant, a dual orexin receptor antagonist, and ethanol in healthy subjects

M. Hoch, J. Hay, P. Hoever, M. de Kam, J. van Gerven, J. Dingemanse

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

215

P.1.c.042 The effects of variation in magnesium soft matter vesicles dosage on behavioural manifestation in rats

L. Tartau, V. Sindrilar, V. Melnig

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

216

P.1.c.043 Midazolam impairs acquisition but not consolidation in water maze paradigm

M.M. Milinkovic, J. Samardzic, J.M. Divljakovic, S.M. Joksimovic, T. Timic, M.M. Savic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

217

P.1.c.044 SH-I-048A, a novel positive modulator of GABA-A receptor: in vitro and behavioral profile

S.M. Joksimovic, S. Huang, J. Ramerstorfer, M.M. Milinkovic, J.M. Divljakovic, B.L. Roth, W. Sieghart, M.M. Savic, J.M. Cook

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

218

P.1.c.045 Ex-vivo serotonin 5-HT1A and 5-HT2A receptor occupancy by asenapine: comparison to olanzapine and risperidone

Y.K. Choi, B. Henry, M. Shahid, F. Tarazi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

219

P.1.c.046 The involvement of opioidergic receptors in the local peripheral anti-hyperalgesic effect of levetiracetam

A. Micov, M. Tomic, R. Stepanovic-Petrovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

220

P.1.c.047 Contribution of a1 subunit-containing GABA-A receptors to diazepam-induced motor impairment

J.M. Divljakovic, M. Van Linn, M.M. Milinkovic, W. Yin, B. Batinic, J.M. Cook, M.M. Savic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

221

P.1.c.048 Modulating effect of new L-valine derivatives on brain serotonin uptake in aggressive socially isolated mice

E. Encheva, S. Stancheva, L. Alova, L. Tancheva, V.V. Petkov, D. Tsekova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 66 KB

english, 2010

222

P.1.c.049 Analysis of interaction between oxcarbazepine and COX-inhibitors in a rat model of inflammatory hyperalgesia

M. Tomic, S. Vuckovic, R. Stepanovic-Petrovic, A. Micov, N. Ugresic, M. Prostran, B. Boskovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

223

P.1.c.050 SRA-444: an example of early drug development decision based on a positron emission tomography study

M. El Gaaloul, S. Raje, A. Lieuwe, W.d. Hirst, T. Andree, S. Chalon

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

224

P.1.c.051 Predictive modeling – impact of varying doses and different formulations on receptor occupancy profile for quetiapine

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

225

P.1.c.052 Effect of combination of ethanol with the orexin receptor antagonist almorexant or zolpidem on motor performance in rats

M.A. Steiner, H. Lecourt, C. Brisbare-Roch, F. Jenck

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

226

P.1.c.053 The effect of olanzapine on a tetrahydrocannabinol-induced increase on the positive and negative syndrome scale

H.D. Kleinloog, M. Liem-Moolenaar, G.E. Jacobs, M.L. de Kam, J.M.A. van Gerven

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

227

P.1.c.054 Sustained administration of bupropion enhances serotonergic and noradrenergic neurotransmission in the rat hippocampus

R. Ghanbari, M. El Mansari, P. Blier

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

228

P.1.c.055 Electrophysiological effects of sustained administration of trazodone on serotonin system

R. Ghanbari, M. El Mansari, P. Blier

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

229

P.1.c.056 Opioid pathways between the inferior colliculus and dorsal periaqueductal grey matter modulate panic-like behaviours

A. Twardowschy, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

230

P.1.c.057 Human psychopharmacology of the kappa opioid agonist salvinorin A

M.W. Johnson, R.R. Griffiths

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 56 KB

english, 2010

231

P.1.c.058 Morphine microinjections in the substantia nigra, pars lateralis, increase fear evoked by inferior colliculus

R. de Oliveira, R.C. de Oliveira, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

232

P.1.c.059 Role of acetylcholine-mediated neurotransmission within pedunculopontine tegmental nucleus in the post-ictal analgesia

R.C. de Oliveira, R. de Oliveira, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

233

P.1.c.060 Revisiting Max Hamilton's model of consensus ratings – a new approach to increase signal detection in CNS drug trials

R. Gaur, M. Sajatovic, N. Lee, L. Ramirez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

234

P.1.c.061 Long term effects of perinatal phencyclidine treatment on the cytochrome c oxidase activity in the rat brain

T. Nikolic, N. Radonjic, N. Petronijevic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

235

P.1.c.062 Effects of glutamic acid on signaling and structural proteins of rat brain endothelial cells in ischaemic conditions

A. Malecki, J. Bernacki, K. Nierwinska, A. Pudelko, A. Dobrowolska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

236

P.1.c.063 Alpha-1-noradrenergic receptor blockade in OCD: an open label add-on study with prazosin

M. Figee, A. Klompmakers, D.A.J.P. Denys

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

237

P.1.c.064 Decreased neuregulin-1 in the cortex of rat pups as immediate effect of perinatal phencyclidine treatment

N. Petronijevic, T. Nikolic, N. Radonjic, U. Vilimanovich, V. Trajkovic, V. Bumbairevic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

238

P.1.c.065 Neuroprotection signalling after electroconvulsive stimulation

D. Rosa, R. Souza, A. Barros, F. Lima, G. Feier, J. Quevedo, M. Romano-Silva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

239

P.1.c.066 Behavioural effects of intranasal dopamine administration

A. Amikishieva, A. Cholodar

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

240

P.1.c.067 Effect of group II metabotropic glutamate receptor agonist on behaviour and electroencephalography in a model of psychosis

M. Fujakova, T. Palenicek, I. Gorman, M. Brunovsky

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

241

P.1.d.001 Marinobufagenin, an endogenous Na pump inhibitor, is implicated in social behavior of mice

V.A. Kashkin, I.V. Belozertseva, E.V. Shekunova, E.E. Zvartau, A.Y. Bagrov

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

242

P.1.d.002 Effect of semi-purified constituent from guaraná seeds on performance of rats in elevated T maze

E.A. Audi, C.M. Roncon, C.B. Almeida, J.C.P. Mello

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

243

P.1.d.003 Advantageous effect of deramciclane in the NaN3 model of Alzheimer's disease in rats

K. Megyeri, K. Móricz, I. Nagyné-Gyönös, M. Albert, I. Gacsályi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

244

P.1.d.004 Cyclooxygenase-2 inhibition by nimesulide may reduce the incidence of pentylenetetrazole-induced seizure in mice

A. Mesdaghinia, A. Heydari, P. Khazaee, H. Yazdanpanah

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

245

P.1.d.005 The effects of ketoprofen and dexketoprofen soft matter vesicles in an experimental pain model in mice

L. Tartau, D. Bindar, V. Melnig

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

246

P.1.d.006 Prenatal administration of analog of the AVP(6–9) analogue Ac-D-MPRG influences on the postpartum behaviour in white rats

O. Voskresenskaya, A. Kamensky, V. Golubovich

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

247

P.1.d.007 Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in rats

M.S. Choi, Y.M. Oh, Y.C. Chung

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

248

P.1.d.008 Diacylglycerol kinase β knockout mice show an abnormal response on psychostimulant-induced behavioural change

H. Hara, K. Kakefuda, M. Ishisaka, A. Oyagi, K. Tsuruma, M. Shimazawa, K. Yokota, N. Saito, K. Fukunaga, J. Takeda

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

249

P.1.d.009 Longterm memory formation in non-association learning task in sham-operated and dentate gyrus lesioned rats

T. Naneishvili, M. Dashniani, G. Beselia, A. Noselidze, L. Kruashvili

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

250

P.1.d.010 Prenatal stress and alcohol produce obsessive-compulsive-like behaviour in mice

M.V. Morozova, N.K. Popova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

251

P.1.d.011 Effects of excitotoxic lesions of the CA1 region of the hippocampus on acquisition of a place and cue water maze task

N. Chkhikvishvili, M. Burjanadze, G. Maglakelidze, R. Sakandelidze

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

252

P.1.d.012 Individual differences in the expression of prepulse inhibition predict the magnitude of amphetamine sensitisation

D. Peleg-Raibstein, J. Hauser, L.L. Lopez, P.A. Gargiulo, J. Feldon, B.K. Yee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

253

P.1.d.013 Influence of D1 and D2 antagonists on mother-dependent behaviour of 10 and 15 days old albino rat pups

I. Stovolosov, V. Dubynin, A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

254

P.1.d.014 HFS and pharmacological inactivation of the globus pallidus and nucleus entopeduncularis differentially affect quinpirole-induced compulsive checking in rats

A. Djodari-Irani, J. Klein, J. Banzhaf, G. Juckel, A. Heinz, A. Kupsch, R. Morgenstern, C. Winter

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

255

P.1.d.015 Postponed influence of neonatal arginine-vasopressin and the arginine-vasopressin fragment Ac-D-MPRG administration to young white rats on behaviour

P. Kim, O.G. Voskresenskaya, A.A. Kamensky, V.P. Golubovich

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

256

P.1.d.016 Acute effects of modafinil on affective behaviour in aggressive and timid male mice

A. Máchalová, D. Vrsková, K. Slais, A. Sulcová

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

257

P.1.d.017 Dissociation between anhedonia, anxiety and brain BDNF levels in a mouse model of social stress

A. Berry, V. Bellisario, S. Capoccia, E. Alleva, P. Tirassa, F. Cirulli

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

258

P.1.d.018 Memory consolidation via membrane glucocorticoid receptors that can be blocked by cannabinoid receptor antagonists

D. Hauer, R.V. Fornari, P. Atsak, P. Campolongo, G. Schelling, B. Roozendaal

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

259

P.1.d.019 Circadian pattern of wheel running activity of four laboratory mouse strains

M. Ágoston, J. Wellmann, P. Delagrange, M. Spedding, I. Gacsályi, G. Szénási

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

260

P.1.d.020 Role of interferon-gamma on anxiety-like behaviour in mice

V.M. Saito, D.H. Rodrigues, A.L. Teixeira, F.A. Moreira

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

261

P.1.d.021 Evaluation of the novel anxiolytic compound BNC210 in a rodent model of cholecystokinin-induced panic

S. O'Connor, B. Huyard, G. Kremmidiotis, S. Wagner, E. Andriambeloson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

262

P.1.d.022 GABAergic synaptic coverage of principal cells in the hippocampus in the rat model of schizophrenia

N. Radonjic, I. Jakovcevski, V. Bumbasirevic, N. Petronijevic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

263

P.1.d.023 Effect of sex hormones on pain-related behaviour in rats

E. Shekunova, A. Malyshkin, I. Belozertseva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

264

P.1.d.024 Acute behavioural effects of nicotine in male mice

I. Belozertseva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

265

P.1.d.025 The involvement of oxidative stress in some cognitive effects of angiotensin II and angiotensin 1–7 in rats

A. Ciobica, L. Hritcu, I. Haulica, R. Popescu, V. Bild

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

266

P.1.d.026 Nicotine ameliorates behavioural deficits and oxidative stress in a 6-hydroxydopamine rat model of Parkinson's disease

A. Ciobica, L. Hritcu, V. Artenie, M. Padurariu, Z. Olteanu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

267

P.1.e.002 Diffusion tensor imaging findings in early-onset schizophrenia patients

M. Gawlowska, P. Gebski, J. Rabe-Jablonska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

268

P.1.e.003 White matter microstructure in transsexuals

E. Gómez-Gil, G. Rametti, B. Carrillo, C. Junque, S. Segovia, A. Gómez, A. Guillamon

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

269

P.1.e.004 Effects of minocycline on regional cerebral blood flow in schizophrenia

C. Marque, C. Chaves, L. Wichert-Ana, J.A.S. Crippa, A.W. Zuardi, G.B. Baker, F.S. Guimarães, S.M. Dursun, J.E.C. Hallak

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

270

P.1.e.005 Delta9-tetrahydrocannabinol (THC) impairs working memory system capacity: a pharmacological MRI study

M.G. Bossong, H.H. van Hell, G. Jager, F.A. Oudman, R.S. Kahn, N.F. Ramsey

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

271

P.1.e.006 Differential brain changes in males with early-onset psychotic disorders by diagnosis

C. Moreno Ruiz, M. Rapado-Castro, S. Reig, J. Castro-Fornieles, A. González-Pinto, J. Janssen, M. Parellada, I. Baeza, M. Desco, C. Arango

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

272

P.1.e.007 Abnormal cortical neurotransmitter levels in young people at familial risk of depression

M.J. Taylor, Z.N. Mannie, R. Norbury, J. Near, P.J. Cowen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

273

P.1.e.008 Impact of genetic polymorphism on resting state functional connectivity in healthy subjects

M.S. Byun, W.H. Jung, J.H. Jang, D.H. Kang, S.J. Kwon, C.H. Choi, J.S. Kwon

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

274

P.1.e.009 Delta9-THC induces non-specific psychotropic effects reflected in resting-state brain function: a pharmaco-imaging study

G. Jager, H.H. van Hell, M.G. Bossong, G. Kristo, R.S. Kahn, N.F. Ramsey

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

275

P.1.e.010 The effect of COMT Val108/158Met Polymorphism on brain activations in response to negative affective facial stimuli

H. Byung-Joo, J. In-Kwa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

276

P.1.e.011 Fronto-limbic interaction of working memory and emotion in the medial prefrontal cortex

G. Pail, W. Huf, C. Kasess, S. Kasper, E. Moser, B. Brocke, A. Meyer-Lindenberg, V.S. Mattay, D.R. Weinberger, L. Pezawas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

277

P.1.e.012 Is there a link between amygdala volume, cognitive function and childhood trauma in first-episode psychosis?

M. Aas, P. Dazzan, A. Gibbs, C. Morgan, H.L. Fisher, A. Reichenberg, J. Zanelli, K. Morgan, R. Murray, C.M. Pariante

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

278

P.1.e.013 Irony comprehension in bipolar disorder: an fMRI study

M. Simon, E. Varga, A.S. Hajnal, G. Orsi, T. Tenyi, S. Fekete, R. Herold

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

279

P.1.e.014 Study on auditory hallucination and delusion using single photon emission computer tomography in schizophrenia

S.K. Wang, J.G. Lee, I.S. Chee, J.L. Kim, S.M. Kim, Y.D. Seo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

280

P.1.e.015 Emotion cognition interaction located using surface-based versus volume-based analysis

W. Huf, G. Pail, B. Hartinger, C. Kasess, S. Kasper, V.S. Mattay, A. Meyer-Lindenberg, E. Moser, D.R. Weinberger, L. Pezawas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

281

P.1.e.016 Cortisol awakening response and cerebral serotonin transporter binding

V.G. Frokjaer, D. Erritzoe, P. Jensen, J. Madsen, W. Baaré, G.M. Knudsen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

282

P.1.e.017 Delta9-THC causes alterations in impulse regulation-related brain function: new insights from a pharmaco-imaging study

K. Noorman, H.H. van Hell, M.G. Bossong, N.F. Ramsey, G. Jager

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

283

P.1.e.018 Focal and global brain measurements in non-psychotic siblings of patients with schizophrenia

H. Boos, W. Cahn, N.E.M. Van Haren, E.M. Derks, R.M. Brouwer, H.G. Schnack, H.E. Hulshoff Pol, R.S. Kahn

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

284

P.1.e.019 Acute administration of the anti-psychotic sulpiride modulates the neural response to chocolate in healthy volunteers

C. McCabe, A. Huber, C.J. Harmer, P.J. Cowen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

285

P.1.e.021 In vivo assessment of changes in serotonin release in the non-human primate brain using PET and [11C]AZ10419369

S.J. Finnema, A. Varrone, T.J. Hwang, L. Farde, C. Halldin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

286

P.1.e.022 Cathechol-O-methyltransferase genotype biases neural correlates of empathy and perceived personal distress in schizophrenia

S. Poletti, D. Radaelli, R. Riccaboni, R. Cavallaro, S. Smeraldi, F. Benedetti

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

287

P.1.e.023 Dopaminergic activity in Tourette's syndrome and obsessive-compulsive disorder

F.E. de Vries, D. Denys, D.C. Cath, M. Figee, D.J. Veltman, T.F. van der Doef, R. Boellaard, A.J.L.M. Balkom, A.A. Lammertsma, B.N.M. van Berckel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

288

P.1.e.024 Effect of antidepressant treatment on the neural circuitry in dysthymia: a functional magnetic resonance imaging study

A. Ravindran, A. Smith, T. Georgescu, C. Cameron, R. Bhatla, M. Hogan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

289

P.1.e.025 Dysfunctional reward circuitry in obsessive-compulsive disorder

M. Figee, M. Vink, F. de Geus, N.C.C. Vulink, D.J. Veltman, H.G.M. Westenberg, D.A.J.P. Denys

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

290

P.1.e.026 [11C]AF150(S): a putative agonist PET ligand for in vivo imaging of the M1 muscarinic acetylcholine receptor

J.E. Leysen, J.C. Buiter, A. Fisher, M.C. Huisman, M. Yaqub, R. Boellaard, A.A. Lammertsma, A.D. Windhorst

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

291

P.1.e.027 Voxel-based morphometry in affected and unaffected offspring of bipolar parents

T. Novak, M. Kopecek, J. Horacek, T. Hajek, C. Hoschl

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

292

P.1.e.028 Increase of whole brain volume and gray and white matter tissue in OCD: a volumetric and voxel-based morphometry MRI study

T. Sobanski, G. Wagner, G. Peikert, U. Gruhn, H. Sauer, R.G. Schlösser

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

293

P.1.e.029 Adolescent stress alters in vivo brain proton magnetic resonance parameters: relevance for impulse-control disorders

E.M. Marco, R. Canese, W. Adriani, F. Podo, G. Laviola

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

294

P.1.e.030 Clinical response of neuronavigated repetitive-TMS in the treatment of auditory hallucinations

M. Klirova, J. Horacek, T. Novak, J. Cermak, B. Tislerova, J. Tintera

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

295

P.1.f.001 Temperament and character profiles in female fibromyalgia syndrome patients and healthy controls

Ö. Altunören, F.O. Orhan, V. Nacitarhan, A. Özer, M.F. Karaaslan, O. Altunören

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

296

P.1.f.002 Personality and help-seeking attitudes of people with mental health problems

K. Krysta, J. Brzezicki, S. Lech, M. Janas-Kozik, A. Klasik

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

297

P.1.f.003 Psychopathology assessment of fifty patients with morbid obesity who applied for bariatric surgery

E. Perez Martinez, C.J. van der Hofstadt, S. Tirado Gonzalez, M. Mateu Vicente

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

298

P.1.f.004 Communal nest reduces vulnerability to depression-like behaviour and enhances brain dopamine function in adult male mice

I. D'Andrea, S. Santarelli, E. Alleva, I. Branchi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

299

P.1.f.005 Risk of development of premenstrual symptoms is associated with a traitlike negative bias in perception of life events

X. Gonda, K.N. Fountoulakis, G. Csukly, T. Telek, D. Pap, Z. Rihmer, G. Bagdy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

300

P.1.g.001 A prospective investigation of postconcussional symptoms after mild traumatic brain injury

R. Hou, R. Peveler, R. Moss-Morris, A. Belli, S. McVeigh, B. Bradley, K. Mogg

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

301

P.1.g.002 Results of adapted sex offenders therapy (SOTSEC-ID) in learning disabled sex offenders in a forensic hospital in UK

P. Kundi, R. Magombedze, D. Sharma

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

302

P.1.g.003 Cognitive and perceptual processing in body dysmorphic disorder

K. Jefferies, K. Laws, G. Hranov, N.A. Fineberg

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

303

P.1.g.004 Deficit in interval timing as a candidate endophenotype for ADHD: evidence from time reproduction and estimation tasks

S. Gau, S. Hwang

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

304

P.1.g.005 Frontal lobe functions in patients with juvenile myoclonic epilepsy treated with valproate or lamotrigine

N. Jovic, D.M. Vucinic, V.A. Milovanovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

305

P.1.g.006 Cognitive function in hepatitis C patients: effect of pegylated interferon a and ribavirin therapy

M. Abd el Meguid, M. Moussa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

306

P.1.g.007 Experimental hyperthyroidism disrupts hippocampal long-term potentiation but not paired pulse facilitation in adult rats

C. Süer, N. Dolu, S. Artis, E. Taskin, L. Sahin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

307

P.1.g.008 Cognitive effects of electrode placement and stimulus dose in brief-pulse electroconvulsive therapy for depression

M. Semkovska, O. Babalola, D. Keane, D.M. McLoughlin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

308

P.1.g.009 Evaluation of an emotional tone discrimination task in humans as a potential method for assessing cognitive bias

M.H. Anderson, E.S.J. Robinson, M.R. Munafo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

309

P.1.g.010 Precuneus hypoperfusion plays an important role in memory impairment of patients with systemic lupus erythematosus

D. Oh, S.H. Kim, Y.Y. Choi, J. Choi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

310

P.1.g.011 Assessing cognitive impairment to define needs for care in a sample of chronic outpatients with schizophrenia

G. Cerveri, V. Venturi, L.S. Volonteri, A. Mazzocchi, C. Mencacci

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

311

P.1.g.012 Functional cognitive consequence of modulating adult hippocampal neurogenesis in the rat

P.J.D. Goetghebeur, R. Dias

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

312

P.1.g.013 Chronic pravastatin but not atorvastatin impairs cognitive function in two rodent models of learning and memory

S.A. Stuart, J.D. Robertson, N.V. Marrion, E.S.J. Robinson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

313

P.1.g.014 Cognitive and neurophysiological performance following scopolamine and ketamine administration in a crossover study

N. Levy-Cooperman, D. Milovan, A. Reches, N. Pinchuk, M.K. Romach, G. Ben Bashat, R. Shani-Hershkovitch, L.Y. Deouell, A.B. Geva, E.M. Sellers

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

314

P.1.g.015 A cognitive behavioural therapy group treatment program for body dysmorphic disorder: preliminary results

C.A.B. Molenaar, N.C.C. Vulink, D.A.J.P. Denys

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

315

P.1.g.016 Nitric oxide donor sodium nitroprusside facilitates induction of long-term potentiation in the dentate gyrus

N. Dolu, S. Artis, C. Suer, S. Aydogan, L. Sahin, S. Bitiktas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

316

P.1.g.017 American ginseng improves human neurocognitive function: a randomized, double-blind, placebo-controlled, crossover study

A. Scholey, A. Ossoukhova, L. Owen, A. Pipingas, M. Kras, A. Ibarra, C. Stough

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

317

P.1.g.018 Genetic, neurophysiologic and behavioural factors in human risk taking behaviour: an endophenotype

I. Heitland, R.S. Oosting, J.M.P. Baas, J.L. Kenemans, K.B.E. Böcker

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

318

P.1.g.019 The effect of acute cold stress on long term potentiation in rats

A.S. Artis, N. Dolu, L. Sahin, A. Cetin, C. Suer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

319

P.1.g.020 Computerised cognitive testing in schizophrenia: patients' experiences

S. Pandey-Bhat, G. Nath, A. Arneja, A. Sharma, H. Kaviani, S. De Santi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

320

P.1.g.021 Comparison of AChE inhibition/5-HT1A blockade in healthy subjects in a scopolamine model of cognitive impairment

V. Parks, A. Patat, S. Raje, K. Wesnes, P. Boeijinga

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

321

P.1.g.022 Decision-making in euthymis bipolar disorders: their relationship with suicidal behaviour

D.J. Martino, S.A. Strejilevich, T. Torralva, F. Manes

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

322

P.1.g.023 No evidence of differences in neurocognitive functioning among euthymic bipolar I and bipolar II disorders

D.J. Martino, A. Igoa, E. Marengo, G. Fassi, S.A. Strejilevich

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

323

P.1.g.024 The influence of corticosteroid receptors on olfactory fear conditioning

R.R. Souza, A.P. Carobrez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

324

P.1.h.001 Comparison of treated and untreated major depressive disorder in a nationwide sample of Korean adults

K. Kim, S. Park, J.W. Choi, J.I. Park, J.P. Hong, M.J. Cho

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

325

P.1.h.002 A different psychiatric diagnosis with similar economic impact in primary care setting: comorbidity and associated cost

M. Blanca-Tamayo, A. Sicras-Mainar, B. Pacual-Arce, N. Muro-Perea, R. Navarro-Artieda, L. García-Sánchez, M.C. Pérez-Navarro

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

326

P.1.h.003 Prevalence of metabolic syndrome and cardiovascular risk in patients with schizoaffective disorders

A. Benabarre, M.P. García-Portilla, L. Livianos, F. Mesa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

327

P.1.h.004 Health-related quality of life of psychiatric disorders and somatic disorders in a nationwide sample of South Korea

S.J. Cho, J.P. Hong, S. Chang, J.Y. Lee, M.J. Cho

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

328

P.1.h.005 Sleep quality and depression among nursing home residents

F.O. Orhan, D. Tuncel, F. Tas, N. Demirci, A. Özer, M.F. Karaaslan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

329

P.1.h.006 Detection of substances of abuse in emergency department: is there an increasing the use of benzodiazepines?

M. Mola Gibert, R. Pou Calvo, L. Montesinos Rueda, E. Gine Serven, A. Alvarez Gomez, E. Batlle de Santiago

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

330

P.1.h.007 Influence of compensation satisfaction on change of health-related quality of life after a flood

S. Min, Y. Joe, M. Kim, J. Heo, J. Shin, S. Koh

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

331

P.1.h.008 Aggression on a psychiatric acute ward: predictors and clinical assessments

M. Stinga, C. Papastergios, K. Papanikolaou, E. Papageorgiou, M. Ntavou, N. Voura, G.F. Angelidis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

332

P.1.h.009 Absolute risk versus risk ratio in Framingham scoring algorithm for prevention of cardiovascular risk

C. Brambilla, C. Siu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

333

P.1.i.001 Sublingual 3.5mg zolpidem for middle-of-the-night insomnia: no tolerance, rebound or increase in use over 4 weeks

T. Roth, N.N. Singh, F. Steinberg, E. Li

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

334

P.1.i.002 Changes in cerebrospinal fluid insulin during non-neurological surgery

S. Bromander, R. Anckarsäter, B. Ahrén, M. Kristiansson, K. Blennow, H. Zetterberg, H. Anckarsäter, C. Wass

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

335

P.1.i.003 Examination of the effects of stimulant treatment across the adult lifecycle of adults with ADHD: a controlled study

J. Biederman, R. Fried, C. Petty, S. Faraone

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

336

P.1.i.004 A randomized, three phase 34 week double-blind long-term efficacy study of extended-release methylphenidate in adults with ADHD

J. Biederman, E. Mick

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

337

p.1.i.005 Long-term functional effects on circadian rhythm caused by a single MDMA treatment

Z. Kátai, T. Garay, B. Balogh, E. Kirilly, G. Bagdy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

338

P.1.i.006 Clinical experience with electroconvulsive therapy at the university hospital in South Korea

H.C. Kim, S.W. Jung

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

339

P.1.i.007 Positive effects of an energy drink on driving performance during prolonged driving

M.A.J. Mets, S. Ketzer, C. Blom, M.H. Van Gerven, G.M. Van Willigenburg, B. Olivier, J.C. Verster

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

340

P.1.i.008 Functions and time scale of self-cutting in subjects suffering from borderline personality disorder

M. Muscionico, K. Dieben, R. Nicastro, N. Perroud, P. Huguelet

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

341

p.1.i.009 Behavioural and neurochemical characterisation of central neuropathic pain after spinal cord transection in the rat

S. MDahoma, R. Massart, F. Chali, D. Orsal, C. Chevarin, V. Kayser, S. Bourgoin, M. Hamon

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

342

P.1.i.010 Depression and anxiety pathway: diagnosis, treatment choice – illustration from Surrey UK

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

343

P.2.a.001 Cyclothymic and hyperthymic temperaments in depressive patients

S. Goto, T. Terao, Y. Araki, N. Hoaki, Y.M. Wang, Y. Takai

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

344

P.2.a.002 The potential of the nicotinic channel blocker tc-5214 as augmentation treatment in patients with major depression

G. Dunbar, D. Hosford

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

345

P.2.a.003 Three polymorphisms of endothelial nitric oxide synthase (eNOS) gene and plasma NO3 levels

A. Ikenouchi-Sugita, R. Yoshimura, T. Kishi, W. Umene-Nakano, H. Hori, K. Hayashi, A. Katsuki, N. Iwata, J. Nakamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

346

P.2.a.004 Early improvement as a predictor of response to antidepressants in resistant depressive patients

M. Bares, T. Novak, M. Kopecek, P. Stopkova, J. Kozeny

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

347

P.2.a.005 Unplanned versus planned suicide attempters: motives, methods, and mental disorders in a Korea-based community sample

H.J. Jeon, J.Y. Lee, Y.M. Lee, J.P. Hong, S.H. Won, S.J. Cho, J.Y. Kim, S.M. Chang, H.W. Lee, M.J. Cho

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

348

P.2.a.006 Predictors of remission in a national sample of patients with depressive disorders: the CRESCEND study

J.M. Kim, J.A. Yoo, S.J. Yang, S.W. Kim, I.S. Shin, J.S. Yoon, J.B. Kim, M.S. Lee, H.W. Lim, T.Y. Jun

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

349

P.2.a.007 Comorbid physical disorders and 12 week treatment outcomes in Korean patients with depressive disorders

J.A. Yoo, J.A. Kim, S.J. Yang, S.W. Kim, I.S. Shin, J.S. Yoon, J.B. Kim, M.S. Lee, H.W. Lim, T.Y. Jun

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

350

P.2.a.008 Gender differences in 12 week treatment outcomes in Korean depressive patients: a report of CRESCEND study

S. Yang, J. Yoo, K. Bae, J. Kim, I. Shin, S. Kim, J. Yoon

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

351

P.2.a.009 Nonadherence to paroxetine; comparison between early-remitters and late-remitters

J. Nakamura, R. Yoshimura, A. Ikenouchi-Sugita, H. Hori, W. Umene-Nakano, A. Katsuki, N. Ueda

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

352

P.2.a.010 The cortisol awakening response in patients remitted from depression

J.M. Aubry, F. Jermann, M. Gex-Fabry, L. Bockhorn, M. Van der Linden, N. Gervasoni, G. Bertschy, F.M. Rossier, G. Bondolfi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

353

P.2.a.011 Cyclothymic and hyperthymic temperaments in depressive patients: supportive evidence for bipolar ii1/2 and iv3

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

354

P.2.a.012 Do we treat different patients with different antidepressant? Clinical and economic assessments in Spanish setting

M. Blanca-Tamayo, A. Sicras-Mainar, B. Pascual-Arce, L. García-Sánchez, M.C. Pérez-Navarro, R. Navarro-Artieda, N. Muro-Perea

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

355

P.2.a.013 Effect of escitalopram on depressive symptoms in patients with coronary artery stents

L.N. Yur'yeva, A.I. Mamchur, A.A. Dukelskiy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

356

P.2.a.014 5-HTTLPR SS depressed women: higher baseline thyroid-stimulating hormone and lower antidepressant response

F. Gressier, S. Trabado, C. Verstuyft, P. Hardy, B. Fève, L. Becquemont, E. Corruble

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

357

P.2.a.015 Transcranial direct current stimulation in patients with treatment-resistant major depressive episode

B. Dell'Osso, S. Zanoni, F. Castellano, C. Dobrea, B. Benatti, C. Arici, R. Ferrucci, M. Vergari, A. Priori, A.C. Altamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

358

P.2.a.016 Cytokine profile in treatment-resistant depression

L.A. Carvalho, J.P. Torre, A.J. Cleare, C.M. Pariante

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

359

P.2.a.017 Acute deep brain stimulation in the subgenual cingulate alters REM sleep in patients with treatment resistant depression

C. Durant, A.L. Malizia, L. Paterson, A. Rich, D.J. Nutt, S. Gill, N.K. Patel, S. Wilson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

360

P.2.a.018 Influences between defense mechanisms and antidepressants on the therapeutic compliance in major depressive disorder

D. Vasile, O. Vasiliu, M.L. Vasile, M. Terpan, A. Mangalagiu, V. Bogdan, D. Ojog, M.B. Petrescu, I. Paraico

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

361

P.2.a.019 Memory and executive functions in patients treated with vagus nerve stimulation for refractory depression

V. Desbeaumes, F. Richer, E. LaGarde, S. Patry, A. Bouthillier, P. Lespérance

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

362

P.2.a.020 Treatment of breast cancer patients with comorbid serious anxiety and depression

Z. Snoj, M. Primic Zakelj, I. Vucko Miklavcic, M. Licina, P. Pregelj

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

363

P.2.a.021 Factors influencing antidepressant adherence in the patients with depressive disorder

D.S. Moon, J.W. Paik, J.W. Kim, A.R. Cho

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

364

P.2.a.022 Current status of geriatric depression treatment in Korea

J. Paik, J. Kim, D. Moon, H. Ko

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

365

P.2.a.023 HPA axis hyperactivity is a vulnerability factor for switch to depressive disorder following interferon treatment

J. Eccles, C. Lallemant, F. Mushtaq, M. Greenwood, M. Keller, I. Haq, J. Tibble, R. Whale

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

366

P.2.a.024 Quetiapine XR monotherapy and quetiapine XR+ongoing antidepressant versus lithium+ongoing AD for Stage II treatment-resistant major depressive disorder

M. Franco Martín, M.L. Figueira, P. Petrov, Z. Rihmer, L. Vavrusová, E. Dencker-Vansvik, L. Jörgensen, J. Köhler, M. Bauer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

367

P.2.a.025 Dopamine transporter gene play a risk factor in patient with major depressive disorder?

C. Huang, M.J. Shy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

368

P.2.a.026 Superior efficacy results of agomelatine in a pooled analysis versus SSRI/SNRI

S. Kasper, A. Hale, P. Lemoine, M.A. Quera Salva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

369

P.2.a.027 Effects of the serotonin type 3A receptor and the cytochrome 2D6*10 genes on citalopram efficacy and side effects in major depressive disorder

J. Paik, J. Kim, H. Ko, S. Lee, E. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

370

P.2.a.028 The effect of the number of depressive episodes on fatigue in female patients with major depression

P. Ferentinos, V.P. Kontaxakis, B.J. Havaki-Kontaxaki, D. Dikeos, G.N. Papadimitriou, L. Lykouras

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

371

P.2.a.029 Pilot study on neurotrophin salivary levels in patients with major depression before and after escitalopram treatment

A. Iannitelli, E. Caroti, G. Bersani, I. Branchi, F. Cirulli, E. Alleva, L. Aloe, P. Tirassa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

372

P.2.a.030 Deliberate self-harm and suicidal ideation in naturalistic outpatients: the Leiden routine outcome monitoring study

M.S. van Noorden, S. de Klerk, A.E. Giezen, P. Spinhoven, M.E. den Hollander-Gijsman, E.J. Giltay, A.E. Speckens, F.G. Zitman

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

373

P.2.a.031 Prednisolone suppression test, but not dexamethasone predicts outcome in treatment resistant depression

M.F. Juruena, C.M. Pariante, A.S. Papadopoulos, L. Poon, S. Lightman, A.J. Cleare

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

374

P.2.a.032 Amantadine: a treatment for major depressive disorder

A. Ruiz-Chow, J. Ramirez-Bermudez, L. Alviso-de la Serna, C. Rios

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

375

P.2.a.033 Therapy of anxiety-depressive disorders in outpatient cardiologic practice

N. Garganeyeva, A.I. Rozin, A.A. Evsyukov, D.S. Kaskayeva, A.V. Donov

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

376

P.2.a.034 Impact of methodology on the efficacy of extended release quetiapine fumarate in major depressive disorder

S. Montgomery, A. Kalali, R.S. McIntyre, W.R. Earley, S. Nyberg, H. Eriksson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

377

P.2.b.001 Water extract of saffron (Crocus sativus) increases brain dopamine and glutamate concentration in the rat

J. Shams, M. Hedayati, F. Asefi, H. Sahraei

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

378

P.2.b.002 Risperidone, an atypical antipsychotic, enhances the effect of antidepressant drugs in animal models of depression

Z. Rogoz, K. Kaminska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

379

P.2.b.003 Control of murine affective behaviour in health and intestinal inflammation by the gut hormone peptide YY

E. Painsipp, H. Herzog, G. Sperk, P. Holzer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

380

P.2.b.004 Interconnectedness of homocysteine and affective disorders

S. Purvina, L. Kevere, D. Bauze, M. Zeibarts, A. Rizevs, S. Jelisejevs, M. Caune, I. Purvins, R. Andrezina

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 65 KB

english, 2010

381

P.2.b.005 The biological pathway underlying dysregulation of hippocampal 5HT1A-NR2B-GSK-3b function in major depression

D. Oh, S.H. Kim, Y.C. Park

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

382

P.2.b.006 Cognitive deficits and salivary cortisol in major depression: effects of treatment

K. Hinkelmann, S. Moritz, C. Muhtz, J. Botzenhard, K. Wiedemann, M. Kellner, C. Otte

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 66 KB

english, 2010

383

P.2.b.007 Time defining effects of tryptophan depletion on hormone secretion and brain 5-HT2 binding in the rat

M. Franklin, I. Bermudez, S. Mucha, N. Singewald, S. Gaburro, H. Murck

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

384

P.2.b.008 Effect of different antidepressants on behavioural alterations induced by chronic social defeat stress

E. Venzala, A.L. García-García, N. Elizalde, P. Delagrange, R. Tordera

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

385

P.2.b.009 Paroxetine and D-cycloserine attenuate deficits in cognitive processes following acute stress: an animal model of PTSD

J. Philbert, P. Pichat, B. BIton, G. Griebel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

386

P.2.b.010 Antidepressant-like features of mice with transgenic activation of Ras in differentiated neurons

O. Leske, Z. Bichler, R. Heumann

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

387

P.2.b.011 In search for a tool selectively evaluating depressive symptoms associated with different neurotransmitter systems

G. Faludi, X. Gonda, V. Bekes, V. Meszaros, A. Sarosi, A. Olah

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

388

P.2.b.012 Transcriptional changes of BDNF and clock genes in the rat prefrontal cortex following acute agomelatine administration

F. Calabrese, R. Molteni, G. Guidotti, C. Gabriel, E. Mocaer, G. Racagni, M.A. Riva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

389

P.2.b.013 Mice with decreased vesicular glutamate transporter VGLUT1 levels show an altered presynaptic 5-HT function

A.L. García-García, N. Elizalde, E. Venzala, J. Del Rio, L. Lanfumey, R.M. Tordera

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

390

P.2.b.014 Desipramine reduces lipopolysaccharide-induced interleukin-1beta in brain and plasma of rats

E. Obuchowicz, A. Prymus, A.M. Bielecka, L. Drzyzga, M. Paul-Samojedny

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

391

P.2.b.015 Mediating role of psychological immune competencies on the development of susceptibility to depression

D. Pap, X. Gonda, J. Lazary, E. Molnar, L. Tothfalusi, G. Bagdy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

392

P.2.b.016 Role of phosphodiasterase 4 variants in depression and therapeutic treatment

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

393

P.2.b.017 Defining endophenoypes in major depressive disorder: anhedonia, neuroticism and psychomotor speed

E. Vrieze, K. Demyttenaere, R. Bruffaert, M. Schmidt, P. de Boer, S. Claes

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

394

P.2.b.018 Mouse communal nest: early social enrichment blunts adult depression-like phenotype altering BDNF epigenetic structure

I. Branchi, I. D'Andrea, S. Santarelli, F. Cirulli, N. Karpova, E. Castrén, E. Alleva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

395

P.2.b.019 Agomelatine has antidepressant effects and modifies BDNF and neuronal plasticity markers in the rat PFC and hippocampus

M. Bianchi, C. Potard, N. Ladurelle, C. Gabriel, E. Mocaer, E.E. Baulieu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

396

P.2.b.020 Changes in gene expression in the rat brain induced by partial serotonergic denervation and chronic variable

A. Alttoa, M. Kanarik, J. Harro

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

397

P.2.b.021 Escitalopram in the treatment of depression

I. Duran, R. Gomez, P. Sanchez, T. Alvarez, A. Chinchilla, M. Vega, A. Cebollada, R. Manzanero, A. Regidor, M. Serrano

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

398

P.2.b.022 Serum BDNF levels correlate with arousal status in women

G. Bersani, A. Iannitelli, P. TIrassa, F. Cirulli, I. Branchi, L. Aloe, E. Alleva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

399

P.2.b.023 Rodent magnesium-deficiency models for depression and their relationship to NMDA receptor/Nitric Oxide pathways

N. Singewald, S.B. Sartori, S. Gaburro, C. Schmuckermair, A. Hetzenauer, A. Rjabokon, M. Franklin, I. Bermudez, H. Murck, J.H. Shin, L. Lin, G. Lubec, N. Whittle

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

400

P.2.b.024 Lithium preferentially increases neurogenesis in the ventral but not dorsal hippocampus of stressed BALB/c mice

O.F. O'Leary, R.M. O'Connor, J.F. Cryan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

401

P.2.b.025 Serotonin uptake in blood platelets is related to cingulate cortex activation

C. Kasess, C. Scharinger, G. Pail, Z. Uzelac, M. Freissmuth, S. Kasper, E. Moser, H. Sitte, L. Pezawas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

402

P.2.c.001 Adding an atypical antipsychotic drug induced a rapid increase of plasma BDNF levels in refractory depression

R. Yoshimura, A. Ikenouchi-Sugita, H. Hori, W. Umene-Nakano, A. Katsuki, K. Hayashi, J. Nakamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

403

P.2.c.002 Efficacy of paroxetine as monotherapy or in combination with sodium valproate in PTSD

G.S. Arslanagic, A. Kucukalic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

404

P.2.c.003 Comparison of Citrus aurantium and imipramine for treatment of major depressive disorder

M. Maroufi, F. Kianvash, M.R. Alavi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

405

P.2.c.004 Response to paroxetine and sodium valproate in PTSD: gender differences, efficacy and tolerability

G.S. Arslanagic, A. Kucukalic, S. Bise

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

406

P.2.c.005 Plasma homovanillic acid levels and 5-HTTLPR gene polymorphism are predictive factors for sertraline in Japanese depressed patients

W. Nakano, R. Yoshimura, N. Ueda, A. Suzuki, A. Ikenouchi-Sugita, H. Hori, K. Otani, J. Nakamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

407

P.2.c.006 The effect of repetitive transcranial magnetic stimulation in major depressive disorder partial remission

C. Charnsil, S. Suttajit, V. Bunyanarutee, S. Lelaput

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

408

P.2.c.007 Efficacy of mirtazapine in depressed outpatients with an enduring personality change after a catastrophic experience

M. Stojakovic, S. Medenica, B. Stojakovic, D. Trkulja, S. Vukadinovic, N. Selman, S. Ristic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

409

P.2.c.008 Assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease

M. Mancini, G. Meco, G. Tedeschi, G. Fabbrini, P. Stanzione, F. Stocchi, R. Ceravolo, M. Guadagna, G. Dell'Agnello, U. Bonuccelli

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

410

P.2.c.009 The effect of major depression, SSRI and gepirone-extended-release treatment on sexual function in women

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

411

P.2.c.010 Comparison of BMI changes associated with various antidepressant treatments during acute depression

M.H. Kang, S.H. Chung, J.N. Bae, J.S. Lee, C.E. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

412

P.2.c.011 The effect of carbamazepine co-therapy on the extent of MAO-A inhibition by moclobemide in depressed patients

A. Rakic Ignjatovic, B. Miljkovic, D. Todorovic, I. Timotijevic, M. Pokrajac

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

413

P.2.c.012 Testosterone gel replacement improves sexual function in hypogonadal depressed men taking antidepressants

R. Amiaz, H. Pope, S.N. Seidman, M. Weiser

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

414

P.2.c.013 New functional variant in SLC6A4 gene as candidate of the individualised treatment of depression – the result of an RCT -

M. Kato, S. Tetsuo, M. Wakeno, S. Nonen, G. Okugawa, Y. Takekita, J. Azuma, T. Kinoshita

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

415

P.2.c.014 Agomelatine: a new therapeutic prospective in depression

C. Istikoglou, D. Foutsitzis, A. Vlavianou, P. Kanellos, N. Polonifis, D. Vlissides, K. Michelidakis, G. Theodorakopoulos

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

416

P.2.c.015 Do our patients comply with antidepressant treatments?

J.I. Castro, S. Oller, M.I. Fernández, L.M. Martín, D. Flamarich, D. Lacasta, R. García, M.T. Font

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

417

P.2.c.016 Sertraline versus mirtazapine in treatment of depression in Parkinson's disease

G. Djokic, D. Pavicevic, N. Zivkovic, M. Nenadovic, N. Nenadovic, D. Duisin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

418

P.2.c.017 Treatment insomnia associated with depression in patients suffering from malignant neoplasm

A. Vasylyeva, S. Tabachnikov

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

419

P.2.c.018 Safety of quetiapine for treatment of insomnia in patients with major depressive disorder

S. Lee, J.H. Han, S.C. Hong, J.H. Jeong, H.J. Seo, H.K. Lim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

420

P.2.c.019 Polypharmacy in psychiatry: clinical practice versus empirical evidence

K. Lötscher, I.G. Anghelescu, S. Braun, R. Bridler, H.H. Stassen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

421

P.2.c.020 Effects of mirtazapine on brain-derived neurotrophic factor (BDNF) and catecholamine metabolites

A. Katsuki, R. Yoshimura, A. Sugita, H. Hori, W. Nakano, K. Hayashi, J. Nakamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

422

P.2.c.021 Agomelatine facilitates positive emotional processing in healthy volunteers

G.M. Goodwin, C. de Bodinat, G.R. Dawson, C.T. Dourish, L. Waldenmaier, S. Adams, P.J. Cowen, C.J. Harmer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

423

P.2.c.023 Sleep architecture in olanzapine treated patients with depression: a double blind randomized placebo controlled trial

R. Milev, L. Lazowski, A. Lowe, R. Jokic, R. du Toit

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

424

P.2.c.024 Switching to second line antidepressant in the United Kingdom: main characteristics and determinants

J. Chollet, D. Saragoussi, N. Despiegel, K. Maman, D. Milea

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

425

P.2.c.025 Effect of duloxetine on chronic tension-type headache in patients with major depressive disorder

H. Kim, K.J. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

426

P.2.c.026 Antidepressants for late-life depression: a meta analysis of placebo-controlled randomized trials

E. Tedeschini, Y. Levkovitz, G. Papakostas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

427

P.2.c.027 The effects of St. John's wort on premenstrual syndrome: a randomised double-blind, placebo-controlled study

H. Suh, J. Ryoo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

428

P.2.c.028 Effect of a single dose (50 mg) of agomelatine on bold fMRI responses to face emotion recognition in healthy volunteers

J. Lees, S. McKie, R. Dadhiwala, P. Horgan, G. Dawson, L. Seguin, E. Mocaër, J.F.W. Deakin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

429

P.2.c.029 Risk factors of drug interaction between warfarin and antidepressant in a clinical setting

R. Na, J.P. Hong, K.W. Kim, J.W. Choi, S.J. Park, K.K. Yi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

430

P.2.c.030 Serum brain-derived neurotrophic factor levels as predictor of antidepressant therapy response

A. Eckert, M. Giese, J. Beck, S. Brand, F. Muheim, M. Hatzinger, E. Holsboer-Trachsler

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

431

P.2.c.031 Genotypic and phenotypic CYP2D6 poor metaboliser status in depressed patients treated with venlafaxine extended release

C. Kane, A. Nichols, V. Chhaya, G. Buckley, C. Guico-Pabia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

432

P.2.c.032 Adjunctive aripiprazole in major depressive disorder (MDD): efficacy and predictors of remission

J.C. Nelson, M.E. Thase, R.A. Baker, L.M. Rollin, R.D. McQuade, R.N. Marcus, R.M. Berman, S.R. Wisniewski, R. Gismondi, J.Y. Loze

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

433

P.2.c.033 Influence and interaction of genetic polymorphisms in serotonin system and early life stress on antidepressant response

Z.J. Zhang, Z. Xu, Y.Y. Shi, M.J. Pu, C.Y. Wang, Z.N. Liu, G.P. Reynolds

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

434

P.2.c.034 Duloxetine versus sertraline in the treatment of post-stroke depression

E. Tzavellas, D. Karaiskos, K. Spengos, E. Economou, G.N. Papadimitriou, I. Liappas, T. Paparrigopoulos

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

435

P.2.c.035 Effect of phospholipase C enzyme gene and environmental factors on antidepressant treatment in Han Chinese population

Z.J. Zhang, Y.Y. Shi, Z. Xu, M.J. Pu, C.Y. Wang, Z.N. Liu, G.P. Reynolds

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

436

P.2.c.036 Associations of gene-gene interaction in the Ras-Raf-MAPK signal pathway with antidepressant drug response

Z.J. Zhang, C.J. Wang, M.J. Pu, Z. Xu, C.Y. Wang, Z.N. Liu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

437

P.2.c.037 The serotonin transporter (SERT) occupancy in median raphe nucleus quantified with PET predicts treatment response to SSRIs in major depressive disorder

E. Akimova, R. Lanzenberger, M. Savli, D. Häusler, W. Wadsak, C. Spindelegger, U. Moser, M. Fink, K. Kletter, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

438

P.2.c.038 Efficacy of levomilnacipran in improving symptoms and functional impairment associated with major depressive disorder

Y. Lecrubier, L. Mansuy, A. Bose, J. Li, P. Werner

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

439

P.2.c.039 Noradrenergic uptake inhibition of higher doses of paroxetine in relation to clinical efficacy: the DELPHI-study

H.G. Ruhe, R. van Westrhenen, M.W. Koeter, M.C. Michel, H.H. Sitte, A.H. Schene

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

440

P.2.d.001 Antidepressant properties of ketamine plus imipramine treatment: behavioural and molecular studies in rats

G.Z. Réus, R.B. Stringari, K.F. Ribeiro, A.K. Ferraro, M.J.S. Frederico, M.F. Vitto, P. Cesconetto, C.T. Souza, J. Quevedo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

441

P.2.d.002 Antidepressant activity of Iranian Corn Silk

M. Mahmoudi, S. Ehteshami

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

442

P.2.d.003 The omega-3 polyunsaturated fatty acid docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia

K. Su, D.Y. Lu, Y.Y. Tsao

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

443

P.2.d.004 The association of glucocorticoid receptor polymorphism with antidepressants treatment response in patients with major depressive disorder

M. Lee, H.S. Chang, Y.J. Jeong, S.J. Kim, H.Y. Lee, B.J. Ham

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

444

P.2.d.006 Role of PSA-NCAM in the structural plasticity associated to dopaminergic antidepressants in the medial prefrontal cortex

E. Castillo-Gómez, M.A. Gómez-Climent, C. García-Mompó, J. Nácher

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

445

P.2.d.007 The influence of aripiprazole on the antidepressant and memory improving effects in rats

E. Nowakowska, L. Kus, A. Czubak, K. Burda, J. Zin, P. Ratajczak

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

446

P.2.d.008 Effects of single and chronic agomelatine administration on Galpha(i) proteins expression in the rat brain

P. Chmielarz, K. Wieczerzak, A. Zelek-Molik, J. Kusmierczyk, A. Bielawski, I. Nalepa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 56 KB

english, 2010

447

P.2.d.009 The role of GIRK channels on the behavioural effects induced by the antidepressant reboxetine

M. Torrecilla, I. Fernandéz-Aedo, L. Ugedo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

448

P.2.d.010 Effects of trazodone and paroxetine on expression of hippocampal AMPA receptors and fEPSPs at CA3/CA1 synapses in rats

E. Gerace, G. Stocca, E. Zianni, M. Magnani, L. Polenzani, L. Olivieri, D. Pellegrini-Giampietro, R. Corradetti

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

449

P.2.d.011 Low dose pipamperone, enhancing antidepressant effect of citalopram, occupies 5HT2A 50–60% leaving D2 nearly drug free

E. Buntinx, K. Bol, P. van den Berg, E. Spaans, L. Haazen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 65 KB

english, 2010

450

P.2.d.012 Role of 5-HT1A receptor on extracellular 5-HT increase induced by trazodone in the rat prefrontal cortex

B. Garrone, S. De Santi, D. D'Amico, G. Mangano, L. Olivieri, M. Magnani, L. Polenzani, A. Guglielmotti

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

451

P.2.d.013 Differential noradrenergic and serotonergic modulation of the neural correlates of the processing of emotional pictures

A.B. Bruehl, T. Kaffenberger, L. Jäncke, U. Herwig

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

452

P.2.d.014 Changes in genes and proteins level of Nr4a1, Egr1 and Id1 in rat brain after antidepressant treatment

M. Gaska, M. Kusmider, J. Solich, A. Faron-Górecka, M. Dziedzica-Wasylewska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

453

P.2.d.015 Adolescent escitalopram administration modifies neurochemical alterations in hippocampus of maternally separated rats

Z.J. Zhang, J.J. Hui, S.S. Liu, G.J. Xi, G.J. Teng, K.C. Chan, G.P. Reynolds

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

454

P.2.d.016 Postweaning enriched environment and citalopram overcome memory deficits and anhedonia induced by maternal separation

Z. Zhang, S.S. Liu, J.J. Hui

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

455

P.2.d.017 Effect of antidepressants on apoptosis of rat cortical neurons subjected to oxygen–glucose deprivation in vitro

A. Pudelko, E. Obuchowicz

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

456

P.2.d.018 Analysis of the effects of chronic antidepressant treatment on neuronal plasticity in middle-aged rats

R. Guirado, S. Hernandez, S. Vidueira, J. Nacher

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

457

P.2.d.019 Prefrontal oscillation associated with randomised, placebo-controlled treatment with agomelatine and psychotherapy

B. Loza, M. Polikowska, M. Szubert-Czarnocka, P. Bednarski, J. Grzesiewska, J. Kwasna, A. Mosiolek, I. Patejuk-Mazurek, P. Wnukiewicz, R. Wojcik

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

458

P.2.d.020 Serum VEGF during electroconvulsive therapy (ECT) in drug resistant depressed patients

A. Minelli, R. Zanardini, M. Abate, M. Bortolomasi, M. Gennarelli, L. Bocchio Chiavetto

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

459

P.2.e.001 Patterns of mood stabiliser drug prescription for Iranian patients with diagnosis of bipolar mood disorder

G. Ahmadzadeh, A. Farhat

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

460

P.2.e.002 Relationship between clinical characteristics, objective psychopathology and subjective deficits of bipolar disorder

S. Joe, D. Kwon, S. Cho

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

461

P.2.e.003 Cys145Ser change in the AKR1C4 gene associated with manic irritability and lower progesterone in male bipolar patients

A.G.M. Johansson, P. Nikamo, M. Landen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

462

P.2.e.004 Neuropsychological and psychosocial impairment in euthymic bipolar patients

E. Mora, I. Forcada, M. Mur, M.J. Portella, N. Vidal, J. Pifarre, E. Vieta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

463

P.2.e.005 Mood stabilisers and atypical antipsychotics in the long-term treatment of bipolar disorder

A.C. Altamura, M. Buoli, R.A. Paoli, D. Primavera

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

464

P.2.e.006 Can we distinguish bipolar from unipolar depression: preliminary results

L.G. Hranov, V. Simov, G. Hranov

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

465

P.2.e.007 Outcome of bipolar illness and comorbid personality disorder

O. Garcia López, P. Fernandez-Argüelles, N. Casas, M. Camacho, J.M. Garcia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

466

P.2.e.008 Initial antidepressant monotherapy in bipolar depression is associated with more depressive relapses and switches

M. Valentí, I. Pacchiarotti, A.M.A. Nivoli, A. Murru, F. Colom, E. Vieta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

467

P.2.e.009 Gender differences in bipolar disorders

A.M.A. Nivoli, F. Colom, A. Rosa R, D. Popovic, I. Pacchiarotti, A. Murru, E. Vieta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

468

P.2.e.010 Effectiveness of quetiapine versus bupropion as adjunctive treatment in bipolar depression

K.J. Lee, H. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

469

P.2.e.011 Correlation between clinical symptoms, serum uric acid level, and beta wave of EEG in patients with bipolar disorder

Y. Lee, D. Han, D. Noh, S. Kim, C. Na

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

470

P.2.e.012 Use of traditional and alternative therapies in people who suffer bipolar disorders: impact on compliance

S. Strejilevich, M. Scapola, D. Martino, M. Sarmiento, L. Gil, C. Gomez Restrepo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

471

P.2.e.013 Effectiveness of quetiapine in bipolar depression patients: a multi-centre, prospective, open-label, observational study

J. Jeong, W.M. Bahk, Y.S. Woo, K.J. Min, D.I. Jon, B.H. Yoon

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

472

P.2.e.014 Combined antidepressant and quetiapine therapy in bipolar I mixed – one-year follow up

G. Callista, E. Daneluzzo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

473

P.2.e.015 Clinical trials to clinical practice: retrospective analysis of 25 patients with bipolar mania treated with aripiprazole

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

474

P.2.e.016 Psychotic versus non-psychotic bipolar II disorder

A. Murru, L. Mazzarini, F. Colom, I. Pacchiarotti, A.M.A. Nivoli, C.M. Bonnin, G.D. Kotzalidis, E. Vieta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

475

P.2.e.017 Life-time suicide attempts in acutely admitted inpatients with bipolar disorder

P.I. Finseth, G. Morken, U.F. Malt, O.A. Andreassen, A.E. Vaaler

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

476

P.2.e.018 Frequency of mixed states in patients with a major depressive episode:the BRIDGE MIX study

G. Perugi, J. Angst, J.M. Azorin, C.L. Bowden, E. Vieta, A.H. Young

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

477

P.2.e.019 Thyroid function assessment in lithium-treated patients: preliminary results

A. Lagoudis, I. Iakovou, T. Christoforidis, C. Stergiokoglou, M. Syngelakis, G. Garyfallos, V. Bozikas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 66 KB

english, 2010

478

P.2.e.020 Treatment with aripiprazole in Korean patients with acute manic or mixed episodes

Y.H. Ko, I.K. Jung, C.S. Han, J.W. Yang, M.S. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

479

P.2.e.021 Aripiprazole in combination with lamotrigine: long-term treatment of patients with bipolar I disorder (manic or mixed)

T. Ketter, B.X. Carlson, W. Sun, K. Timko, E. Vester-Blokland, R.D. McQuade, R. Sanchez, R. Owen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

480

P.2.e.022 Lamotrigine adjunctive therapy and possible sleep regulation in adult autism spectrum disorder: a case report

K. Ooga, Y. Abe, T. Okudaira, Y. Suzuki, Y. Ishikawa, Y. Furukawa, T. Kojima

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

481

P.2.e.023 Switching from olanzapine to ziprasidone in patients with bipolar disorder: a 24-weeks, multi-center open-label trial

B. Yoon, W. Bahk, H. Lee, Y. Woo, Y. Kwon, A. Bae, M. KIm

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

482

P.2.e.024 Cytokine profiles in bipolar affective disorder during acute episodes and in remission

A. Remlinger-Molenda, P. Wojciak, A. Kostrzewa, J. Karczewski, K. Wiktorowicz, J.K. Rybakowski

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

483

P.2.e.025 The risk of drug–drug interactions in the treatment of bipolar disorder

M. Vrabie, V. Marinescu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

484

P.2.e.026 Parenting and family planning characteristics among bipolar mothers compared to controls

D. Hupfeld Moreno, D. Bio, S. Petresco, D. Petresco, E. Gutt, R.A. Moreno

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

485

P.2.e.027 Association of body mass index with depression and alexithymia

A. Karagöl, G. Ozcurumez, N. Taskintuna

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

486

P.2.f.001 Lithium treatment is not associated with functional or autoimmunitarian thyroideal abnormalities in bipolar disorder I

J. Cobo, E. Patró, J.D. Barbero, M. Pérez, C. Domènech, G. Severino, J.A. Monreal, O. Jiménez-Palop, F. Bleda, G. García-Parés

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

487

P.2.f.002 Selective DNA methylation of BDNF promoter in bipolar disorder

C. D'Addario, B. Dell'Osso, D. Galimberti, E. Scarpini, B. Arosio, L. Bergamaschini, C. Fenoglio, S. Candeletti, P. Romualdi, A.C. Altamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

488

P.2.f.003 No state-dependent alternation of immunological parameters, insulin, and leptin during bipolar depression

S.Y. Tsai, K.H. Chung, S.H. Huang

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

489

P.2.f.004 Anti-estrogenic drugs do not reproduce the antimanic-like effect of tamoxifen in methylphenidate-induced hyperlocomotion

R. Andreatini, M. Pereira, B.J. Martynhak, I.P. Baretta, D. Correia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

490

P.2.f.005 Pharmacological treatment in bipolar I and II disorders

N. Varela Gómez, N. Ferrier, J. Mayoral-Van Son, T. Moreno Calle

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

491

P.2.g.001 Association of mood depression with inflammation and oxidative stress in peritoneal dialysis patients

S. Park, Y. Jung, J. Park, H. Shin, H. Rim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

492

P.2.g.002 Sexual dysfunction in depressed subjects with enduring personality change (F62.0) taking mirtazapine

M. Stojakovic, S. Vukadinovic, B. Stojakovic, D. Trkulja, S. Medenica, N. Selman

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

493

P.2.g.003 The effect of antipsychotic combination with antidepressants to reach remission in elderly depressive patients

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

494

P.2.g.004 Bupropion for adults with ADHD: meta-analysis of randomised, placebo-controlled trials

N. Maneeton, B. Maneeton, S. Srisurpanont

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

495

P.2.g.005 Prescription of antipsychotics in inpatients with major depressive disorder in 2000 and 2007 – results from the AMSP pharmacovigilance project

K. Papageorgiou, A. Konstantinidis, R. Grohmann, A. Horvath, R. Engel, S. Kasper

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

496

P.2.g.006 Vagus nerve stimulation in treatment-resistant depression (TRD): results from a systematic neuropsychiatric investigation

E. LaGarde, P. Lespérance, S. Patry, V.S. Tourjman, V. Desbeaumes, A. Bouthillier

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

497

P.2.g.007 Standard antidepressant therapy vs association between amisulpride and antidepressant therapy in atypical depression

G. Grigorescu, A. Baloescu, D. Vasile, C. Tudor, O. Vasiliu, R. Grigorescu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

498

P.2.g.008 Efficacy of milnacipran in patients with interferon-a2 induced depression

M. Zavoianu, A. Cantemir, C. Tudor, G. Grigorescu, D. Vasile

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

499

P.2.g.009 The incidence of psychiatric disorders in patients with hyperthyroidism

R. Chenderes, D.M. Podea, L. Stamoran, P.D. Nanu, C. Mila, L.E. Piros, N. Mihailescu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

500

P.2.g.010 Taurine levels in plasma before and after three ECT treatments

M. Samuelsson, G. Gerdin, M. Vrethem

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

501

P.2.g.011 Implications of oxidative stress in patients with depressive disorder and insomnia

R. Vitalaru, M. Padurariu, A. Cantemir, A. Ciobica, C. Stefanescu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

502

P.2.h.001 Polymorphisms in the BDNF gene are associated with antidepressant treatment response

J. Hennings, M. Kohli, A. Heck, D. Roeske, T. Brückl, T. Klengel, A. Menke, B. Müller-Myhsok, M. Ising, F. Holsboer, S. Lucae

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

503

P.2.h.002 Chronic stress induces changes in neuronal plasticity and inhibitory neurotransmission in the amygdala of adult mice

J. Gilabert-Juan, E. Castillo-Gomez, M.D. Moltó, J. Nàcher

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

504

P.2.h.003 Suicide attempts in a mental health unit of Galicia

B. Pórtela Traba, M. Pérez García, A. Mozos Ansorena

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

505

P.2.h.004 Antidepressant and antipsychotic-like effects of GABA-B receptor ligands in mGlu7 deficient mice

J.M. Wieronska, P. Branski, T. Lech, M. Marciniak, A. Pilc

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

506

P.3.a.001 Evaluation of the effect of aripiprazole on quality of life in patients with schizophrenia

C. Bervoets, E. Constant, B. Sabbe, M. Morrens, K. Vansteelandt, A. De Patoul, D. Pitzi, V. Halkin, J.Y. Loze, J. Peuskens

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

507

P.3.a.002 Evaluation of theta burst stimulation on the resistant auditory hallucinations: a pilot study

D. Sidhoumi, S. Braha, N. Bouaziz, R. Benadhira, D. Januel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

508

P.3.a.003 Comorbidity of dandy walker complex malformations and schizophrenia, case series

E. Yildizhan, G. Özgen, A. Türkcan, Z. Öztürk

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

509

P.3.a.004 Clinical variables, cognitive assessment and positron emission tomography (PET) in schizophrenic inpatients

M. Buoli, E. Caletti, M. Serati, R.A. Paoli, B. Dell'Osso, A.C. Altamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

510

P.3.a.005 The impact of cannabis use on cognitive functioning in schizophrenia: a meta-analysis of existing findings and new data

M. Yücel, E. Bora, D.I. Lubman, N. Solowij, W.J. Brewer, S. Cotton, P. Conus, A. Fornito, P.D. McGorry, C. Pantelis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

511

P.3.a.006 Attitudes concerning depot medication in German general population – a representative telephone survey

J. Cordes, S. Arnau, K. Hoppe, J. Thünker, I. Wittib

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

512

P.3.a.007 Subjective well-being in schizophrenia is inversely correlated with the presence and severity of depressive symptoms

J. Sanjuan, J.M. Haro, J. Maurino, T. Diez, J. Ballesteros

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

513

P.3.a.008 Factors affecting treatment discontinuation and treatment outcome in patients with schizophrenia: a 10-year follow-up study

H.J. Choi, S.H. Jung, C.E. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

514

P.3.a.009 Negative symptoms: neglected but important targets for treatment

R. Hunter, S. Barry

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

515

P.3.a.010 Visual processing abnormalities as biomarker for schizophrenia: an EEG study in the schizophrenia spectrum

I. Koychev, W. El-Deredy, C. Haenschel, J.F.W. Deakin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

516

P.3.a.011 Descriptive study of suicidal behaviour in delusional disorder

M. Pérez García, A. Mozos Ansorena, B. Portela Traba, M. Páramo Fernández, J. Brenlla González

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

517

P.3.a.012 Alteration in resting state brain connectivity in subjects with high genetic risk of psychosis

J.H. Jang, W.H. Jung, E. Kim, G. Shim, H.Y. Park, D.H. Kang, C.H. Choi, J.S. Kwon

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

518

P.3.a.013 Fatigue, sleepiness and sleep quality in psychotic disorders

C. Widakowich, D. Neu, V. Nagant, G. Steegen, P. Verbanck

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

519

P.3.a.014 Factors influencing patients' experience of stigma in the outpatients with schizophrenia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

520

P.3.a.015 Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients

Y. Inoue, H. Suzuki, M. Ootomo, S. Takeda, Y. Kawaguchi, K. Gen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

521

P.3.a.016 Importance of demographic factors and neuropsychological functioning in schizophrenic patients treated with olanzapine

K. Krysta, A. Borkowska, M. Bielinski

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

522

P.3.a.017 Global functioning amongst patients at a psychiatric emergency service: preliminary results

N. Manzanares, A. García-Villarrubia, S. Arranz, O. González, A. Sáenz, J. Peña

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

523

P.3.a.018 A role for structural equation modeling in subtyping schizophrenia in an African population

L. Koen, D.J.H. Niehaus, R.A. Emsley, E. Jordaan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

524

P.3.a.019 Discontinuity of treatment with antipsychotics and neurostructural changes in an animal model

D. Marinescu, L. Mogoanta, T. Udristoiu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

525

P.3.a.020 Weight gain as a marker of evolution to patients with multiple episodes schizophrenia and depressive symptoms

I. Marinescu, D. Marinescu, M. Pirlog, A. Chimorgiachis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

526

P.3.a.021 Prepulse inhibition in patients with first-episode of schizophrenia: differences related to cannabis abuse disorder

I. Morales, G. Rubio, R. Jurado, M. Caballero, I. Martínez-Gras, G. Ponce, M.A. Jiménez-Arriero, T. Palomo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

527

P.3.a.022 QoL of schizophrenic inpatients treated with risperidone or haloperidol

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

528

P.3.a.023 The relationship of the clinical characteristics of Korean schizophrenia with serum homocysteine and folate levels

T.H. Kim, S.W. Moon

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

529

P.3.a.024 Risk for coronary heart disease in inpatients with serious mental illness

P. Ntounas, C. Tsopelas, I. Vlachos, I. Sovolakis, E. Gkeka, R. Psaras, E. Siouti, C. Touloumis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 56 KB

english, 2010

530

P.3.a.025 Metabolic syndrome in inpatients with serious mental illness

P. Ntounas, I. Vlachos, R. Psaras, C. Tsopelas, I. Sovolakis, E. Gkeka, M. Dimitraka, E. Siouti, C. Touloumis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

531

P.3.a.026 Safety, tolerability and D2 occupancy of the fast dissociating D2 antagonist JNJ-37822681 in healthy subjects

M. Schmidt, P. de Boer, E. Mannaert, T. Iersel, L. van Nueten

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

532

P.3.a.027 Prediction of un-planned readmission to hospital for patients with schizophrenia – a cohort-study of 277 patients

R. Kroken, L.S. Mellesdal, H.A. Jørgensen, T. Wentzel-Larsen, E. Johnsen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

533

P.3.a.028 Gender differences in suicidal behaviour of patients with depressive disorders

N.O. Maruta, L.T. Snovida

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

534

P.3.a.029 Acute and transient psychosis: focus on clinical features and stressful life events before the first episode

E. Rancans, M. Rusaka

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

535

P.3.a.030 Deformities caused by stable body posture in two cases with chronic psychotic disorder

M. Hacioglu, E. Ugurlu, E. Yildirim, S. Erek, O. Saatcioglu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

536

P.3.a.031 Service utilisation of schizophrenic patients treated with long-acting injectable risperidone in Taiwan

H. Chang, K. Su, P. McCropne

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

537

P.3.a.032 Sexual dysfunction in a Tunisian sample of drug free schizophrenic patients: a case-control-study

Y. El Kissi, S. Gaabout, M. Laaroussi, M. Ayachi, J. Nakhli, B. Ben Hadj Ali

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

538

P.3.a.033 Electrophysiological measures and clinical scales in schizophrenia and bipolar disorder

N. Domján, G. Csifcsák, I. Szendi, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

539

P.3.a.034 Elaboration on the association between immigration and schizophrenia: a population based national study

N. Werbeloff, S.Z. Levine, J. Rabinowitz

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

540

P.3.a.035 Cognitive responce as a predictor of repetitive transcranial magnetic stimulation (rTMS) efficacy in schizophrenia

N. Maslenikov, E.E. Tsukarzi, S.N. Mosolov

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

541

P.3.a.036 Cognitive impairment: response to a depot antipsychotic in a South African first-episode psychosis cohort

R. Schoeman, P.P. Oosthuizen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

542

P.3.a.037 Hyperactivation of inflammatory response in depressed patients with psychomotor retardation

G. Camardese, B. Leone, B. Mattioli, G. Pizi, P. Bria

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

543

P.3.a.038 Cannabis-induced psychosis: new entity?

Z. Makkos, L. Fejes, G. Inczedy-Farkas, A. Kassai-Farkas, J. Lazary

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

544

P.3.a.039 Prescribing behaviour of psychiatrists: data from the clinical analysis of the treatment of schizophrenia (CATS) project

N. Bergemann, P. Parzer, F. Rommel, M. Franz, M. Lautenschlager, J. Kammerer-Ciernioch, G. Schindler, P. Wallenfels, M. Weisbrod, M. Deuschle

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

545

P.3.a.040 Reasons for admission of psychotic patients to psychiatric emergency services

R. Florea, H. Ho Quoc, P.H. Courtet

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

546

P.3.b.001 Seasonality of serum melatonin concentrations in paranoid schizophrenic inpatients

E. Díaz Mesa, A. Morer Fumero, P. Abreu-González, A. Jiménez-Sosa, M. Henry, L. Fernández-López, A. Intxausti, R. Gracia-Marco

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

547

P.3.b.002 Peculiarities of psychotic migrant Romanian patients

A.M. Vremaroiu, L. Fodoreanu, I. Miclutia, C. Popescu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

548

P.3.b.003 Mapping brain regions in which deep brain stimulation affects schizophrenia-like behaviour in rats – a pilot study

J. Klein, C. Eberhardt, A. Männer, J. Baldassarri, R. Morgenstern, C. Winter

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

549

P.3.b.004 Advanced paternal age generates higher risk for schizophrenia than for alcohol addiction

B.I. Dragomir, C.N. Marginean, M. Valcu, L. Fodoreanu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

550

P.3.b.005 Proton magnetic resonance spectroscopy measures predict a short-time symptomatic outcome in chronic schizophrenia

A. Szulc, B. Galinska, E. Tarasow, B. Kubas, B. Konarzewska, R. Poplawska, N. Waszkiewicz

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

551

P.3.b.006 Evidence of reduced tiiodothyronine in refractory schizophrenics under clozapine: cause or effect?

P. Belmonte-de-Abreu, C.S. Gama, M.I. Lobato, H. Brentani, R. Massuda, J.A. Palha

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

552

P.3.b.007 Epistasis between variations located in TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotics

T. Jun, C. Pae, H.R. Wang, A. Serretti

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

553

P.3.b.008 Postsynaptic density-95/93 in rat hippocampus affected by NR1/NR2 antisense oligodeoxynucleotide

M. Vrajova, V. Bubeníková-Valeová, M. Fujáková, J. Klaschka

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

554

P.3.b.009 Interaction analysis of apolipoprotein D and dopamine D2 receptor gene variants in schizophrenia

P.Z. Álmos, S. Horváth, A. Juhász, Z. Janka

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

555

P.3.b.010 Examination of nociceptive behaviour and stress reactivity in susceptibility gene mutant models of schizophrenia

C. O'Tuathaigh, J. Walsh, O. Tighe, M. Karayiorgou, J. Gogos, R. Harvey, D. Lai, J.L. Waddington

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

556

P.3.c.001 Association between HTR2C polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

A. Risselada, J. Vehof, R. Bruggeman, B. Wilffert, D. Cohen, A.F. Al Hadithy, J. Arends, H. Mulder

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

557

P.3.c.002 Association between the alpha-2a-adrenergic receptor 1291 C/G polymorphism and the metabolic syndrome

A. Risselada, J. Vehof, R. Bruggeman, B. Wilffert, D. Cohen, A.F. Al Hadithy, J. Arends, H. Mulder

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

558

P.3.c.003 A randomized, controlled study to evaluate quetiapine fumarate in improving sleep quality of schizophrenia

B. Zhang, F.J. Jia, P. Zhou

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

559

P.3.c.004 Anticholinergic prescribing patterns in patients receiving treatment with antipsychotic medication

F. Oosthuizen, K. du Toit, A.N. Khumalo, N.N.P. Shinga, T. Pillai, K. Pillay, S. Kanhai, T.S. Nhlapo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

560

P.3.c.005 Association of antipsychotic polypharmacy with health service cost – a Danish register-based cost-minimisation analysis

L. Baandrup, J. Sørensen, H. Lublin, M. Nordentoft, B. Glenthøj

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

561

P.3.c.006 Olanzapine in the treatment of anorexia nervosa: a case report

A. Capasso, C. Petrella, W. Milano

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

562

P.3.c.007 Compliance of outpatients using long acting antipsychotics with supportive outreaching: a matched case control study

H. Van Loon, H. Vandenbroele, S. De Bruyne, A. Wybo, M. Glorieux, V. Dubois, B. Gillain, J. Peuskens

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

563

P.3.c.008 Correlation between psychotic symptoms and sleep disturbances in schizophrenia

J. Leszczynska, A. Paliga, J. Wieczorek, K. Krysta, I. Krupka-Matuszczyk

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

564

P.3.c.009 Effects of switching to risperidone long-acting injection on cognitive function in schizophrenia

H. Suzuki, Y. Inoue, M. Otomo, Y. Kawaguchi, K. Gen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

565

P.3.c.010 Risperidone and olanzapine comparison for weight changes in a 24 months open extension study

D. Begic, S. Bise, O. Cemalovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

566

P.3.c.011 Olanzapine long-acting injection vs oral olanzapine in schizophrenia outpatients: a 2-year, randomized, open-label study

H. Detke, P.J. Weiden, T. Lambert, P.M. Llorca, M. Choukour, S.B. Watson, E. Brunner, H. Ascher-Svanum

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

567

P.3.c.012 Paliperidone for the treatment of hyperactive delirium: short-term, open-label trial

C. Han, H.K. Yoon, Y.H. Ko

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

568

P.3.c.013 Risperidone in the treatment of depressive episodes and drug induced delirium in a patient with somatic comorbidity

S. Bise, D. Begic, B. Kurtovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

569

P.3.c.014 The impact of the subjective response to antipsychotics on the course of illness in schizophrenic patients

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

570

P.3.c.015 Haloperidol versus atypical antipsychotics in the long-term treatment of schizophrenia

A.C. Altamura, M. Buoli, M.C. Mauri, B. Dell'Osso

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

571

P.3.c.016 Cognitive functions and dosage of antipsychotic drugs in Japanese schizophrenia patients

H. Hori, R. Yoshimura, A. Katsuki, K. Hayashi, A. Sugita, W. Nakano, J. Nakamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

572

P.3.c.017 Polish patients of the EUFEST study after 1 year antipsychotic treatment: drug discontinuation and metabolic syndrome parameters

J. Rabe-Jablonska, T. Pawelczyk, M. Jarema, M. Olajossy, J. Rybakowski

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

573

P.3.c.018 The characteristics of pharmacotherapy for inpatients with schizophrenia: a multicentre comparative study in Asia

W. Nakano, R. Yoshimura, S. Yang, N. Shinfuku, S. Fujii, T. Hoshuyama, K. Sim, M. Chong, C. Tan, J. Nakamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

574

P.3.c.019 Community treatment orders and psychotropic medication: baseline data analysis for a one year follow up study (N= 200)

M.X. Patel, J. Matonhodze, M. Baig, J. Gilleen, J. Boydell, F. Holloway, D. Taylor, G. Szmukler, T.J. Lambert, A.S. David

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

575

P.3.c.020 Olanzapine in serum and cerebrospinal fluid in patients with schizophrenia or schizoaffective disorder

E. Skogh, I. Sjödin, M. Josefsson, M.L. Dahl

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

576

P.3.c.021 Intramuscular aripiprazole versus injectable haloperidol in treatment of acute psychotic agitation

C. Istikoglou, A. Vlavianou, D. Foutsitzis, G. Theodorakopoulos, C. Polonifis, P. Kanellos, D. Vlissides

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

577

P.3.c.022 Comparison of patients treated with antipsychotics and psychoeducation and those treated with antipsychotics only

C. Istikoglou, D. Foutsitzis, G. Theodorakopoulos, P. Kanellos, N. Polonifis, A. Vlavianou, D. Vlissides, K. Michelidakis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

578

P.3.c.023 Glycine plasma levels are not a useful predictor of recovery in patients treated with glycine and neuroleptics

D. Strzelecki, J. Rabe-Jablonska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

579

P.3.c.024 Prevalence of and factors associated with nonadherence to antipsychotic drugs in patients with schizophrenia

S. Suttajit, S. Pilakanta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

580

P.3.c.025 Heart rate variability in patients with chronic schizophrenia switching from risperidone to paliperidone

T.T. Chen, J.Y. Chen, Y.C. Wang, H.S. Yeh, G.H. Mo, I.C. Lai

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

581

P.3.c.026 Risperidone depot versus zuclopenthixol depot for schizophrenia and schizophrenialike psychoses: real world outcomes

V. Fricchione Parise, G. Balletta, G. Manna

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

582

P.3.c.027 The influence of DRD2 and endothelial nitric oxide synthase (eNOS) polymorphisms, prolactin and antipsychotics on sexual function in schizophrenic patients

X.R. Zhang, Z.J. Zhang, R.X. Zhu, Y.G. Yuan, T.A. Jenkins, G.P. Reynolds

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

583

P.3.c.028 Olanzapine in treatment of delusional disorders

N. Zivkovic, D. Pavicevic, G. Djokic, M. Nenadovic, N. Nenadovic, J. Lekovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

584

P.3.c.029 A study to examine the efficacy and safety of amisulpride according to the different initial dosages in schizophrenia

J.H. Lee, K.H. Lee, J.O. Song, S.J. Lee, D.K. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

585

P.3.c.030 Serotonin-1A receptor gene polymorphism and the ability of antipsychotic drugs to improve attention in schizophrenia

T. Sumiyoshi, M. Tsunoda, Y. Higuchi, T. Itoh, T. Seo, H. Itoh, M. Suzuki, M. Kurachi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

586

P.3.c.031 Risk of metabolic, cardiologic, and endocrinologic abnormalities in patients under long-term antipsychotic treatment

G. Cerveri, A. Mazzocchi, L.S. Volonteri, C. Mannussakis, C. Mencacci

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

587

P.3.c.032 Long-acting risperidone injection versus conventional depots in chronic psychotic patients: a 54 months study

S.L. Romero Guillena, N. Casas Barquero, J.L. Velez Noguera, R. Fernandez-Villamor Ortiz

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

588

P.3.c.033 Predictors for treatment response in non-acute patients with schizophrenia

A. Schreiner, C. Tessier, D. Hoeben, M. Lahaye, J. Pfeil, J. Peuskens, F. Rosa, D. Naber, E. Smeraldi, S. Djukic-Dejanovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

589

P.3.c.034 A 6-month naturalistic study of outcome in schizophrenic out-patients, treated with olanzapine

M. Krzystanek, I. Krupka-Matuszczyk

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

590

P.3.c.035 QUALITY: a non-interventional study evaluating QOL in schizophrenic patients treated with atypical antipsychotics

J. Peuskens, C. Taeter, V. Duquenne

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

591

P.3.c.036 Antipsychotics prescribing pattern of patients with schizophrenia admitted to Korean general hospital: 2001 to 2008

H.J. Choi, S.H. Jung, C.E. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

592

P.3.c.037 A prospective randomized controlled trial of paliperidone ER versus oral olanzapine in patients with schizophrenia

C. Tessier, D. Hoeben, P. Korcsog, D.J.H. Niehaus, K. Aadamsoo, A. Ücok, M. Franco, P. Theodoropoulou, R. Salinas, A. Schreiner

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

593

P.3.c.038 Quetiapine and norquetiapine efficacy in axiety and depression in major psychosis: a pharmacokinetic approach

M. Mauri, B. Dell'Osso, M. Buoli, S. Paletta, D. Moliterno, S.R. Bareggi, A.C. Altamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

594

P.3.c.039 Effects of neuroleptic treatment on oxidative stress parameters in schizophrenia patients

A.S. Ivanova, L.P. Smirnova, N.M. Krotenko, A.V. Semke

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

595

P.3.c.040 Treatment adherence and tolerability of high doses of risperidone longacting injectable in severe schizophrenic patients

J.j. Fernandez-Miranda, I. Gancedo-Alvarez, M. Redondo-Alvarez, V. Carames-Garcia, A. Sanchez-Garcia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

596

P.3.c.041 A randomized, double-blind study of paliperidone palmitate and risperidone long-acting therapy in schizophrenia

G. Pandina, R. Lane, S. Gopal, C. Gassmann-Mayer, D. Hough, B. Remmerie, G. Simpson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

597

P.3.c.042 Antipsychotic polypharmacy and excessive doses are not associated with attentional flexibility in schizophrenia

D. Kontis, S. Kleisas, E. Theochari, S. Kalogerakou, A. Andreopoulou, S. Vassilouli, S. Papakonstantinou, C. Karouzos, E. Tsaltas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

598

P.3.c.043 Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia

I. Espiño Díaz

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

599

P.3.c.044 Antipsychotic polypharmacy in a community psychiatric clinic

C. Willis, K.S. Naidoo, P. Sawhney

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

600

P.3.c.045 Neuroleptic malignant syndrome after addition of ziprasidone to long-term treatment with risperidone

M. Markopoulou, K. Bobotas, V. Theodori

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

601

P.3.c.046 Efficacy and safety of JNJ 37822681, a fast dissociating D2 receptor antagonist, in the treatment of schizophrenia

M. Schmidt, L. Janssens, J. Kent, I. Anghelescu, G. Hüsken, V. Sinha, E. Mannaert

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

602

P.3.c.047 Six-months clinical trial of paliperidone extended-release in schizophrenia patients

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

603

P.3.c.048 Treatment with antipsychotics in hospitalised patients with maniac episode

M.C. Garcia Mahia, M. Vidal Millares, M. Gonzalez Santos, C. Armas Barbazan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

604

P.3.c.049 Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia

T. Jun, Y. Jeon, H. Lee, K. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

605

P.3.c.050 Interaction between polymorphisms of oxidative enzymes and susceptibility to tardive dyskinesia in psychiatric patients

S.A. Ivanova, A.F.Y. Al Hadithy, P. Pechlivanoglou, A.V. Semke, O.Y. Fedorenko, L.A. Levchuk, E.G. Kornetova, J.R.B.J. Brouwers, R. Bruggeman, A.J.M. Loonen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

606

P.3.c.051 The effect of ziprasidone on the QTc interval when used in combination with lithium, valproate or lamotrigine

H. Meltzer, O.N. Karayal, J. Miceli, S. Kolluri, C. O'Gorman

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

607

P.3.c.052 Overdose of paliperidone: a case report

J.M. Olivares, C. Cinos, C.P. Losada, F.J. Gutiérrez, M. López

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

608

P.3.c.053 Reasons for switching between antipsychotic drug treatments – the international antipsychotic drug substitution registry

B. Galinska-Skok, P. Paterakis, M. Bubrovszky, P. Thomas, G. Perdriset, L. Pani

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

609

P.3.c.054 Effect of the DRD2 Taq 1A polymorphism on perospirone and aripiprazole efficacy for Japanese schizophrenia patients

Y. Takekita, M. Kato, M. Wakeno, S. Nonen, S. Tetsuo, S. Sakai, A. Suwa, G. Okugawa, T. Kinoshita

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

610

P.3.c.055 Asenapine: short-term tolerability, safety, and pharmacokinetic profile in older patients with psychosis

S. Dubovsky, C. Frobose, P. Phiri, J. Panagides

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

611

P.3.c.056 Prolactin elevation induced by antipsychotics in first episode psychotic patients

R. Perez-Iglesias, I. Mata, M.T. Garcia-Unzueta, J.A. Amado, O. Martinez-Garcia, J.L. Vazquez-Barquero, B. Crespo-Facorro

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

612

P.3.c.057 Which patients switch antipsychotic medication? Data from the international Antipsychotic Drug Substitution Registry

P. Paterakis, B. Galinska-Skok, L. Pani, M. Bubrovszky, G. Perdriset, P. Thomas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

613

P.3.c.058 Clozapine-induced agranulocytosis in monozygotic twins and association with multidrug resistance gene MDR1 polymorphisms

A.E. Anil Yagcioglu, B. Cetin Ilhan, M.T. Goktas, M.O. Babaoglu, E. Uz, M.K. Yazici

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

614

P.3.c.059 Oxidative stress status in schizophrenic patients treated with typical versus atypical antipsychotics

M. Padurariu, I. Dobrin, C. Stefanescu, A. Ciobica, R.P. Dobrin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

615

P.3.c.060 Aripiprazol in the treatment of catatonia -review of the literature and case reports

V. Voros, T. Tenyi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

616

P.3.c.061 Paliperidone palmitate response in acutely ill patients with schizophrenia previously treated with oral risperidone

J.K. Sliwa, C.A. Bossie, Y.W. Ma, A. Schreiner, J.T. Haskins, L. Alphs

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

617

P.3.c.062 The efficacy and safety of the novel antipsychotic cariprazine in acute exacerbation of schizophrenia

A. Bose, D. Li, R. Migliore, P. Werner, G. Nemeth, I. Laszlovszky

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

618

P.3.c.063 QoL, global functioning and social adaptation of schizophrenic subjects treated with long-acting risperidone

S. Tosic Golubovic, V.S. Sibinovic, V.S. Slavkovic, Z.O. Zikic, D.G. Gugleta

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

619

P.3.c.064 Serum lipide profiles during antipsychotic treatment of schizophrenic subjects

V.S. Slavkovic, S.T.G. Tosic Golubovic, D.G. Gugleta, V.S. Sibinovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

620

P.3.c.065 Comparison of multifactor dimensionality reduction (MDR) and neural network analysis: serotonergic system genes and antipsychotic response

V. De Luca, R.P. Souza, A. Tiwari, H.Y. Meltzer, S.G. Potkin, J. Volavka, J. Lieberman, J.L. Kennedy, A. Serretti

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

621

P.3.c.066 Efficacy and safety of long-acting risperidone in schizophrenic stable subjects durring 6 months period

D.G. Gugleta, V.S. Slavkovic, S.T.G. Tosic Golubovic, V.S. Sibinovic, S.D. Stankovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

622

P.3.c.067 One year study: efficacy of haloperidol versus risperidone in the treatment of schizoaffective disorder

D. Siladji Mladenovic, S. Drezgic Vukic, B. Golubovic, A. Ivezic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

623

P.3.c.068 Psychopharmacological influence in effectiveness of psychotherapeutic programs in a psychiatric day hospital population

J. Aguado, O.M. Segurado

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

624

P.3.c.069 Dosage patterns – lessons learned from the e-STAR database in Czech Republic

E. Cesková, J. Kopriva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

625

P.3.d.001 Evaluation of clinical and functional outcomes in low-adherent to treatment patients with bipolar disorder in Spain

E. Medina, J.M. Montes, C. De Dios, A. Rodriguez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

626

P.3.d.002 Cognitive impairment in patients with psychotic disorder diagnosis

L. Barbadillo, J. Carton, E. Ibarburu, L. Martin, M. Artola

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

627

P.3.d.003 Effects of olanzapine on structure and function of brain tissue biomolecules during unpredictable chronic mild stress: an Fourier transform mid-infrared spectroscopic study

I. Komsuoglu, E. Gumuslu, S. Turker, O. Mutlu, F. Yildiz, F. Erden

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

628

P.3.d.004 Influence of aripiprazole, risperidone, and amisulpride on PPI and P50-suppression in healthy males with low levels of gating

P.A. Csomor, F.X. Vollenweider

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

629

P.3.d.005 Activity of phosphodiesterase 10A inhibitors in a novel animal model of negative symptoms of schizophrenia

B. Langen, D. Zschaber, H. Stange, T. Hage, N. Brandon, K. Marquis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

630

P.3.d.007 Phencyclidine decreases tickled-induced 50-kHz calls in juvenile rats: a model for schizophrenia

D. Boulay, S. Ho-Van, O. Bergis, P. Avenet, G. Griebel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

631

P.3.d.008 Massive creatin kinase and hepatic enzymes elevation due to quetiapine and valproic acid treatment

S. Erdogan, F.C. Celikel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

632

P.3.d.009 Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia

X. Langlois, A. Megens, H. Lavreysen, R. Wouters, L. Peeters, P. te Riele, H. Hendrickx, M. Mahieu, M. de Bruyn, G. Macdonald

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

633

P.3.d.010 Antipsychotic drugs induce dopamine type 2 receptor mediated suppression of neuronal firing in the rat nucleus incertus

R. Rajkumar, M.N. Lee, G.S. Dawe

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

634

P.3.d.011 Follow up screening for the metabolic syndrome in patients receiving antipsychotic treatment

L. Konstantinidou, T. Tsouvalas Athanasios, G. Georgiou Georgia, B. Birmpili Euaggelia-Maria

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

635

P.3.d.012 Action of clozapine depends on dopamine receptors presence on target cells -functional study

A. Faron-Gorecka, M. Kusmider, M. Gaska, K. Szafran, J. Solich, P. Palach, M. Dziedzicka-Wasylewska

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

636

P.3.d.013 Energetic metabolism, leptin are altered in rats submitted to chronic administration of olanzapine

A. Zugno, M. Barcelos, D. Fraga, L. Oliveira, L. Canever, R. Luca, G. Rezin, G. Scaini, E. Streck, J. Quevedo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

637

P.3.d.014 Continuous paliperidone infusion versus repeated risperidone injections on cognition, prolactinemia and body weight in rats

L. Pani, S. Ruiu, G. Casu, C. Dessì, G. Pinna Spada, A.L. Deriu, G. Marchese

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

638

P.3.d.015 Treatment with memantine and imipramine induces changes in mitochondrial respiratory chain activity in the rat brain

D. Fraga, G. Réus, R. Stringari, G. Rezin, J. Daufenbach, E. Streck, J. Quevedo, A. Zugno

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

639

P.3.d.016 Involvement of histaminergic receptors in the atypical antipsychotic profile of clozapine and N-desmethylclozapine

M. Humbert-Claude, E. Davenas, F. Gbahou, J.M. Arrang

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

640

P.3.d.017 Psychotropic medication use profile and adequacy in elderly institutionalised population

B. Pascual Arce, M.C. Perez Navarro, L. Garcia Sanchez, N. Muro Perea, A. Sicras Mainar, M. Blanca Tamayo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

641

P.3.e.001 Facial emotion recognition deficit in schizophrenia: a replication study in Korean subjects

S.J. Lee, H.D. Rim, Y.W. Park, J.J. Lee, S.M. Jang, J.M. Woo, H.Y. Jo, K.U. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

642

P.3.e.002 Aggressive behaviour among psychiatric inpatients in Psychiatric Hospital Hronovce (Slovakia) during the years 2006–2008

M. Zelman, A.C.H. Das, A. Priscakova, J. Hudec

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

643

P.3.e.003 Effectiveness of olanzapine standard oral and orally disintegrating tablets in a 1-year European observational study

F. Chartier, F. Rouillon, M. Lukasiewicz, S. Kraemer, Y. D'yachkova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

644

P.3.e.004 Standardisation of Korean version of Launay-Slade Hallucination Scale-Revised

H. Jung, Y. Kim, S.H. Kim, Y.S. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

645

P.3.e.005 Total blood cholesterol levels and serum creatine kinase activity in violent psychiatric inpatients

I. Reznik, S. Kertzman, H. Grinspan, M. Birger, N. Shlapnikov, H.Y. Meltzer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

646

P.3.e.006 The utility of the MMPI-2 and PAI for discriminating the patients with schizophrenia and depression in Korea

M.C. Park, Y.H. Ko, S.W. Oh, J.I. Park

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

647

P.3.e.007 Sexual activity and marital relationships in Tunisian schizophrenic patients: comparison with healthy controls

Y. El Kissi, M. Laaroussi, S. Gaabout, M. Ayachi, J. Nakhli, B. Ben Hadj Ali

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

648

P.3.e.008 Activation of the immune system with respect to cognitive functioning in schizophrenia

D. Frydecka, A. Beszlej, M. Szewczuk-Boguslawska, M. Zagdanska, L. Karabon, E. Pawlak, A. Kiejna

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

649

P.3.e.009 Clinical analysis of the treatment of schizophrenia (CATS)-study: module assessment of sexual functions

M. Lautenschlager, W. de Millas, A. Lehmann, M. Lambert, K. Leopold, M. Franz, M. Deuschle

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

650

P.3.e.010 Inhaled loxapine (AZ-004) rapidly improves acute agitation in patients with schizophrenia or bipolar disorder

J.V. Cassella, R.S. Fishman, D. Spyker

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

651

P.3.f.001 The impact of language and culture on the delivery of standardised rater training for the PANSS across seven countries

A. DeFries, C. Yavorsky, S. Liechti, M. Opler

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

652

P.3.f.002 Quantifying rater drift in a sample of standardised rater training events: Is PANSS reliability maintained over time?

A. DeFries, C. Yavorsky, M. Opler, L. Ramadhar, E. Ivanova, J. Gordon, S. Jovic, L. Yang

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

653

P.3.f.003 Effect of clozapine on behavioural and cytokine profiles in rats with lipopolysaccharide and viral protein stimulation

H. Tejkalová, T. Ruml, M. Rumlová, J. Klaschka, S. Ruzicková

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

654

P.3.f.004 Coping strategies in individuals with serious and prolonged mental disorders

J. de Santiago Sastre, M.A. Sánchez Peña

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

655

P.3.f.005 Different forms of risperidone and haloperidol in sexual dysfunction among schizophrenic male patients

V. Sibinovic, S. Tosic-Golubovic, D. Gugleta, G. Selimovic, O. Zikic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

656

P.3.f.006 Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviours in mice

A. Ortega-Álvaro, A. Aracil-Fernández, M.S. García-Gutiérrez, F. Navarrete, J. Manzanares

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

657

P.3.f.007 Atypical antipsychotics and effects of muscarinic and serotonergic receptor binding on insulin secretion in a rat model

M.K. Hahn, A.F. Chintoh, L. Lam, S.W. Mann, A. Giacca, P. Fletcher, G. Remington

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

658

P.3.f.008 The relationship between insight and psychosis in schizophrenic Romanian patients

C. Crisan, C. Bondor, R. Macrea

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

659

P.3.f.009 A raised glucocorticoid receptor alpha/beta expression ratio in monocytes of schizophrenic and bipolar patients

K. Weigelt, A. Spijker, R.C. Drexhage, J.M. Wijkhuijs, H.A. Drexhage

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

660

P.3.f.010 Continuous perfomance test dysfunction in delusional disorder: an fMRI investigation

F. Akyuz, S. Oflaz, A. Hamamci, Z. Firat, M. Cihangiroglu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

661

P.3.f.011 Nitric oxide inhibitor blocks methylphenidate-disruptive effect on prepulse inhibition and modifies limbic c-Fos expression

A. Issy Pereira, E.A. Del Bel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

662

P.3.f.012 Psychoneuroimmune interactions in schizophrenia

O. Lobacheva, T.P. Vetlugina

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

663

P.4.a.001 Quality of life outcomes in obsessive-compulsive disorder: relationship to treatment response and symptom relapse

N.A. Fineberg, D.J. Stein, M. Legault, F. Marteau, E. Hollander

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

664

P.4.a.002 Does tobacco-smoking indicate an impulsive subtype of OCD? A case-control study

N.A. Fineberg, P. Sharma, T. Gale

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

665

P.4.a.003 Are tics an essential symptom of the obsessive-compulsive syndrome?

G. Hranov, N.A. Fineberg

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

666

P.4.a.004 A comparison of different types of obsessions due to brain damage

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

667

P.4.a.005 The prevalence of metabolic syndrome in patients with obsessive-compulsive disorder: a cross-sectional analysis

B. Goksan Yavuz, O. Karamustafalioglu, B. Bakim, B. Ozcelik, Y. Cengiz Ceylan, I. Erensoy, O. Tankaya, E. Turkyilmaz, H. Yumrukcal, E. Toprak

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

668

P.4.a.006 Differences in duration of untreated illness in patients with anxiety disorders

B. Dell'Osso, M. Buoli, L. Lietti, L. Oldani, G. Camuri, B. Benatti, E. Catenacci, C. Bressi, A.C. Altamura

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

669

P.4.a.007 Verbal memory deficits in patients with posttraumatic stress disorder with and without major depression

M.J. Nijdam, M. Olff

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

670

P.4.a.008 Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder

J. Greist, M. Liu-Dumaw, D. Feltner

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

671

P.4.a.009 Efficacy of pregabalin in generalised social anxiety disorder: results of a placebo-controlled, fixed-dose study

D. Feltner, R. Bielski, M. Liu-Dumaw

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

672

P.4.a.010 Evaluation of the pharmacokinetics and clinical tolerability of the novel anxiolytic BNC210 in healthy volunteers

G. Kremmidiotis, S. O'Connor, E. Doolin, P. Rolan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

673

P.4.a.011 Neuropsychological effects of nucleus accumbens deep brain stimulation surgery for obsessive-compulsive disorder

M. Mantione, D. Nieman, R. Schuurman, D. Denys

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

674

P.4.a.012 Preliminary results of therapists' adherence in a randomised clinical cognitive-behavioural therapy trial for panic disorder and agoraphobia

C. Hauke, A.T. Gloster, H.U. Wittchen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

675

P.4.a.013 Critical elements of cognitive behavioural therapy (CBT) for panic disorder with agoraphobia: a preliminary examination of the influence of exposure

A.T. Gloster, M. Höfler, H.U. Wittchen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

676

P.4.a.014 Alcohol use and drinking motivation in posttraumatic stress disorder patients: a case-control study

H. So, H. Jung, J. Choi, T. Kim, M. Chung, S. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

677

P.4.a.015 Investigation of predictors of drug response in obsessive compulsive disorder (OCD)

P. Richter, K. Witheridge, Z.J. Daskalakis, J. Deluce, R. Nebitt, N. Rector, A. Levitt, J.L. Kennedy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

678

P.4.a.016 Occurrence of traumatic brain injuries in patients with chronic posttraumatic stress disorder

M. Simonovic, M. Radisavljevic, G. Grbesa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

679

P.4.b.002 Effects of novel 3,4-dimethoxyphenyl-ethylamine derivates on anxiety-like behaviour: a pilot study

J. Fedotova, V. Barishpolec, G. Markarov

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 66 KB

english, 2010

680

P.4.b.003 Distinct role of the ventral hippocampus in two different animal models of anxiety

V.C.S. Amaral, R.L. Nunes-de-Souza

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 49 KB

english, 2010

681

P.4.b.004 Investigation of effects of fluoxetine on unpredictable chronic mild stress-induced changes of brain tissue by Fourier transform mid-infrared spectroscopy

S. Turker, O. Mutlu, I. Komsuoglu, E. Gumuslu, F. Yildiz, F. Erden

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

682

P.4.b.005 Type-2 cannabinoid receptor (CB2r) overexpression results in reduced response to anxiogenic-like stimuli and impaired anxiolytic action of alprazolam

M. García-Gutiérrez, J. Manzanares

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

683

P.4.b.006 Interpreting the social scene: threat detection and cost attribution in social anxiety

K.S. Button, M.R. Munafò, G. Lewis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

684

P.4.b.007 Effects of ventrolateral periaqueductal gray lesion on nociception, locomotion and anxiety-like indices in mice

J. Mendes-Gomes, R.L. Nunes-de-Souza

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

685

P.4.b.008 Beta-adrenoceptor stimulation by isoproterenol promotes olfactory fear conditioning in rats

E. Pavesi, N.S. Canteras, A.P. Carobrez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 50 KB

english, 2010

686

P.4.b.009 Posttraumatic stress disorder and inflammation

G. Mkrtchyan, L. Hovhannisyan, A. Boyajyan, M. Tadevosyan, A. Kalashyan, S. Sukiasian

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

687

P.4.b.00l Neuropeptide S receptor (NPSR) gene – imaging genetic evidence for a role in panic disorder

K. Domschke, P. Ohrmann, A. Pedersen, C. Hohoff, J. Bauer, T. Suslow, H. Kugel, V. Arolt, A. Reif, J. Deckert

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

688

P.4.b.010 Coping strategies in depression and/or panic disorder compared to healthy controls

L. Timmerman, R. Ploeger

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

689

P.4.b.0111 The aversive state induced by periaqueductal gray stimulation modulates the reconsolidation of a fear memory

C. Mochny, G.C. Kincheski, V.A. Molina, A.P. Carobrez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

690

P.4.b.012 Acute anxiolytic drug treatment has no effect on the instrumental successive negative contrast effect using a modified forced choice serial reaction time task

E.N. Mitchell, H. Marston, D. Nutt, E.S.J. Robinson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

691

P.4.b.013 Effect of diazepam on conditioned fear evoked by an ethological model of panic involving prey versus predator encounters

M.A. Castiblanco-Urbina, A. Twardowschy, A. Uribe-Mariño, A. Francisco, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

692

P.4.b.014 Effects of diazepam on fear behaviours evoked by a model of panic involving prey versus predator confrontations

A. Francisco, M.A. Castiblanco-Urbina, A. Twardowschy, A. Uribe-Mariño, N.C. Coimbra

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

693

P.4.b.015 Development of autistic symptoms under chronic social defeat stress in anxious male mice: effects of diazepam

N.N. Kudryavtseva, I.L. Kovalenko

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

694

P.4.b.016 Ventromedial prefrontal cortex activity is required for anxiety expression: distinct neurochemical mechanisms evidence

C.A.J. Stern, F.H. Do-Monte, L. Gazarini, A.P. Carobrez, L.J. Bertoglio

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

695

P.4.b.017 D2 dopamine receptor (DRD2) gene polymorphism and combat-related posttraumatic stress disorder in Vietnam veterans

J.H. Choi, T.Y. Kim, K. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

696

P.4.b.018 Examining face and construct validity of a non-invasive model of panic disorder in lister-hooded rats

E. Prinssen, L.B. Nicolas, C. Lopez Lopez, L.H. Jacobson, S. Gatti, C. Grundschober, S. Klein

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

697

P.4.b.019 Panic attacks associated with generalised anxiety disorder

M. Van Ameringen, C. Mancini, W. Simpson, B. Patterson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

698

P.4.b.020 Serum BDNF in OCD and major depressive disorder patients before and during antidepressant treatment

L. Bocchio Chiavetto, G. Rosso, R. Zanardini, A. Chiarle, F. Bogetto, M. Gennarelli, G. Maina

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

699

P.4.c.001 Efficacy of repetitive transcranial magnetic stimulations in the management of obsessive compulsive disorder

H. EL-Sawy, A.D.E.L. Badawy, M. Abdelhay

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

700

P.4.c.002 Anxiolytic effect of cannabidiol in subjects with social anxiety disorder

M.M. Bergamaschi, M.H.N. Chagas, D.I. Chaves, B.S. Martinis, M.D. Grando, M.C. Freitas, R.H.C. Queiroz, J.E.C. Hallak, A.W. Zuardi, J.A.S. Crippa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

701

P.4.c.003 Ondansetron augmentation in resistant OCD: relapse in symptoms following discontinuation of ondansetron

S. Pallanti, S. Antonini, S. Bernardi, E. Hollander

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

702

P.4.c.004 Comparison of effect of paroxetine and milnacipran for outpatients with pain disorder

K. Sanada, M. Mimura, Y. Noda, M. Hida, M. Nakahara, A. Tsukurimichi, Y. Kawamura, N. Kato

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

703

P.4.c.005 Anxiety treatment and health related quality of life improvement with sertraline of outpatients with chronic heart failure

N. Ibishi, V. Kola, N. Musliu

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

704

P.4.c.006 Day 3&7 jitteriness symptoms predict poor 6 week outcome in SSRI treatment and correlate with day 7 nocturnal activity

D. Christmas, S.J.C. Davies, D.A. Hince, J. Williams, K. Schroeder, D.J. Nutt

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

705

P.4.d.001 Influence of peptide bioregulator on hormones in therapy of patients with organic disorders

L. Ryadovaya, S. Ivanova, V. Semke

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

706

P.4.d.002 Electroencephalographic activity defines the temporal-window for pentylenetetrazole role as an unconditioned stimulus

J. Cavalli, A.A. Hoeller, M. Duzzioni, T.C.M. De-Lima, L.J. Bertoglio, A.P. Carobrez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

707

P.4.e.001 Lost productivity time among workers with panic disorder and the improvement after 12 weeks of pharmacotherapy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

708

P.4.e.002 Clinical differences between PTSD and adjustment disorders in adolescent

M. Lee, J. Lee, S. Park

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

709

P.4.e.003 Clomipramine and quetiapine augmentation for obsessive compulsive disorder compared to sustained fluoxetine treatment

J.B. Diniz, C.A.B. Pereira, E.C. Miguel, R.G. Shavitt

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

710

P.4.e.004 SSRI treatment-induced weight loss is associated with a 5-HT2C receptor polymorphism

M.M. Oros, O.O. Yevtushenko, G.P. Reynolds

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

711

P.4.e.005 Obsessionality in the general population and in psychiatric disorders

R.M. Blom, C. de Bruijn, R. de Graaf, M. ten Have, D. Denys

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

712

P.4.e.006 Aripiprazole augmentation of antidepressant therapy of severe obsessive-compulsive disorder: a preliminary study

M. Casale, R. Braiotta, C. Cerruti, E.P. Di Pierro, T. Guerriero, F. Maucioni, A. Morello, T. Tortorella, A. Mautone

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

713

P.5.a.001 Disease system analysis approach to model Alzheimer's disease progression in patients on stable acetylcholine esterase inhibitor therapy

R. Gomeni, M. Gold, M. Zvartau-Hind, M. Irizarry, D. Austin, M. Simeoni

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

714

P.5.a.002 Accessing treatment and services for people with dementia: a pilot study

R. Spencer, S. Curran, N. Roberts, V. Minogue, J. Shewan, J. Wattis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

715

P.5.a.003 The validity of the Korean version of brief cognitive rating scale (BCRS)

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

716

P.5.a.004 Effect of food supplement F containing ferulic acid and angelica archangelica on behavioural disorder of dementia

K. Kanaya, S. Abe, M. Sakai, H. Fujii, K. Koizumi, T. Iwamoto

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

717

P.5.a.005 An open label study of mirtazapine in the treatment of depression with Alzheimer's disease

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

718

P.5.a.006 Methylphenidate augmentation of cholinesterase inhibitors for the treatment of apathy associated with Alzheimer's disease

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

719

P.5.a.007 Comparative efficacy of cholinesterase inhibitors in dementia associated with Parkinson's disease

D. Vasile, O. Vasiliu, M.L. Vasile, M. Terpan, G. Grigorescu, V. Bogdan, A. Mangalagiu, M.B. Petrescu, D. Ojog

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

720

P.5.a.008 The effectiveness of risperidone on behavioural and psychological symptoms of dementia

C.H. Lee, Y.D. Kim, D.-Hee Kim, D.-Hong Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

721

P.5.a.009 Relationship between subjective memory complaints and cognitive function in the elderly

K.Y. Lim, K.J. Chang, K.S. Lee, H.J. Kim, H.K. Cheong, B.H. Oh, C.H. Hong

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

722

P.5.a.010 Association between memory age identity and cognition in the elderly

K.Y. Lim, K.J. Chang, H.J. Kim, K.S. Lee, H.K. Cheong, B.H. Oh, C.H. Hong

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

723

P.5.a.011 Correlation of plasma homocysteien and folate levels with white matter changes in Alzheimer's disease patients

S.G. Kim, H.Y. Jung, S.Y. Lee, E.Y. Shin, W.Y. Jung, J.H. Park

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

724

P.5.a.012 Effects of memantine on global clinical status in patients with moderate Alzheimer's disease

S.M. Graham, R.K. Hofbauer, S. Hendrix, M. Tocco, J.L. Perhach

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

725

P.5.a.013 Memantine prevents worsening across multiple domains in a trial of patients with moderate Alzheimer's disease

S.M. Graham, M. Tocco, S. Hendrix, R.K. Hofbauer, M.L. Miller, J.L. Perhach

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

726

P.5.a.014 Functional communication in patients with moderate Alzheimer's disease treated with memantine

S. Graham, M. Tocco, S. Hendrix, R.K. Hofbauer, J.L. Perhach

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

727

P.5.a.015 Psychometric properties of the Turkish version of the Cohen-Mansfield agitation inventory

E.T. Ozel-Kizil, G. Bastug, S. Erdogan, D. Sakarya

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

728

P.5.a.016 Automated classification of MR images for recognising Alzheimer's disease in living patients

F. Simsek, F. Polat, O. Demirel, O. Kitis, D. Haznedaroglu, C. Eker, E. Kumral, A.S. Gonul

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

729

P.5.a.017 Effects of memantine on language and functional communication in patients with moderate to severe Alzheimer's disease

M. Tocco, S.M. Graham

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

730

P.5.a.018 Validity of semantic memory test as predictor of change in ADAS-cog scores in mild cognitive impairment

E. Kornsey, B. Friedmann, M. Murphy, N. Cutler

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 48 KB

english, 2010

731

P.5.b.001 Longitudinal [11C]PIB and [18F]FDDNP PET studies on memory in patients and controls

R. Ossenkoppele, N. Tolboom, W.M. van der Flier, M. Yaqub, A.D. Windhorst, R. Boellaard, F. Barkhof, A.A. Lammertsma, P. Scheltens, B.N.M. van Berckel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

732

P.5.b.002 Neuroprotective therapy in basic treatment of vascular dementia

I. Suvorova, V. Shprakh

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

733

P.5.b.003 Psychopharmacological intervention in cognitive impairment comorbid with medical and/or psychiatric pathology

A.I. Ledo, I. Sanchez, I. López, A. Soto, P. Marqués

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

734

P.5.c.001 Memantine improves poststroke cognitive impairment supported with mirtazapine

S. Djukic Dejanovic, D. Djokic, D.R. Milovanovic, M. Borovcanin, D.B. Ravanic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

735

P.5.c.002 Eating disorders and deep brain stimulation of the subthalamic nucleus in Parkinson's Disease

I. Chéreau, I. De Chazeron, I. Rieu, P.p. Derost, J.j. Lemaire, P.m. Llorca, F. Durif

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

736

P.5.c.003 Psychiatric comorbidity and quality of life in patients candidates to epilepsy surgery

L. Camara Pestana, M. Andreia, A. Carmo, R. Mendes, S. Loureiro

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

737

P.5.d.001 1-Benzyl-1,2,3,4-tetrahydroisoquinoline inhibits L-DOPA-induced increase of dopamine metabolism in rat brain

A. Wasik, M. Kajta, I. Romanska, L. Antkiewicz-Michaluk

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

738

P.5.d.002 The protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on rotenone-induced irregularities in rat brain

L. Antkiewicz-Michaluk, A. Wasik, I. Romanska, J. Boksa, J. Michaluk

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

739

P.5.d.003 Effects of resveratrol on scopolamine and mecamylamine induced memory impairment in rats

N. Gacar, T. Utkan, O. Mutlu, S.S. Göçmez, I. Komsuoglu Celikyurt, G. Ulak

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

740

P.5.d.004 Neuroprotective effect of cerebrolysin and erythropoietin versus haloperidol in an Alzheimer's disease – animal model

L. Mogoanta, D. Marinescu, T. Udristoiu, I. Udristoiu, D. Pirici

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

741

P.5.d.005 Midazolam microinjected into inferior colliculus potentiate haloperidol-induced catalepsy

L. Melo, J.G. Tostes, P. Medeiros, N.C. Coimbra, E.A.M. Ferrari

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

742

P.5.d.006 Pro-and antioxidant mechanisms in patients in different clinical forms of multiple sclerosis current in treatment

L. Smirnova, N. Krotenko, V. Alifirova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 64 KB

english, 2010

743

P.5.d.007 Effects of 5-HT7 receptor ligands in rats suffering from chronic neuropathic pain

F. Viguier, B. Michot, V. Kayser, M. Hamon, S. Bourgoin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

744

P.5.e.001 Patient characteristics for misdiagnosed delirium at psychiatric consultation in a university hospital

K.W. Yun, J.W. Choi, H.S. Park, J.H. Ryoo, Y.C. Kim, W.J. Lim, E.J. Kim, S.I. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

745

P.5.e.002 Comparison between effectiveness of aripiprazole and risperidone for treatment of delirium in hospitalized patients

J.K. Sakong, S.W. Jung, J.S. Kim, B.H. Koo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

746

P.5.e.003 ZOOM: observational genetic screening study of Niemann-Pick disease type C in adults with neurological/psychiatric signs

H. Klünemann, F. Sedel, D. Linden, D. Balding, J.E. Wraith, M.C. Patterson, M. Pineda, J. Priller, C. Remy, P. Bauer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 47 KB

english, 2010

747

P.5.e.004 The impact of site rater monitoring and refresher training on enrollment in a mild cognitive impairment phenotype trial

B. Friedmann, E. Kornsey, M. Murphy, N. Cutler

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

748

P.5.f.001 Age-related changes in brain white matter hyperintensities of Korean elderly: its impact on mood and cognition

H.S. Kim, B.I. Yoo, T.H. Kim, K.W. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

749

P.6.a.001 Differences in the clinical features and temperament and character between hospitalised male and female alcoholics

J.S. Lee, S.B. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

750

P.6.a.002 Clinical trial of escitalopram for alcoholism comorbid with affective disorders

E. Krupitsky, S. Yerish, A. Kiselev

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

751

P.6.a.003 Long acting risperidone in heavy-drinkers: a preliminary study of efficacy

M. Marinescu, S. Bisleau, V. Ferri, S. Bulteau, S. Voillet, S. Pradayrol, Y. Bescond, M. Lejoyeux

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

752

P.6.a.004 Serum glutamate dehydrogenase in alcoholics

M. Kravos, I. Maleic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

753

P.6.a.005 Inpatient alcoholics and level of motivation for abstinence using university of Rhode Island change assessment scale

B.J. Jung, D.K. Lee, H.J. Kim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 56 KB

english, 2010

754

P.6.a.006 Clinical variables related to attentional bias associated with alcohol cues

F. Trujillo, M. Marín, J. Chamorro, P. Curibil, L. Sánchez-Pastor, I. Martínez-Gras, G. Ponce, G. Rubio

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

755

P.6.a.007 Influence of neuroactive peptidic preparations on apoptosis of immunocompetent cells in alcoholic patients

N. Bokhan, E.V. Zhernova, S.A. Ivanova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

756

P.6.a.008 Changes in alcohol use following flood disaster according to pre-disaster alcohol use: a 2-year prospective study

J. Shin, M.H. Kim, S. Min

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

757

P.6.a.009 Profiling Type I and Type II alcoholics using psychometric questionnaires in a Greek patient sample

G. Ntantouti, G. Kiosterakis, E. Segredou

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

758

P.6.a.010 Alterations of brain-derived neurotrophic factor serum levels in alcohol dependence patients

R. Zanardini, A. Fontana, M. Gennarelli, L. Bocchio-Chiavetto

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

759

P.6.a.011 Adequacy of decision making is not associated with long-term abstinence in alcohol addiction

B. Andó, A. Szkaliczki, E. Kurgyis, N. Domján, J. Honti, I. Demeter, P. Szikszay, Z. Janka, P. Almos

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

760

P.6.b.001 Ethanol inhibits neurotransmission in the nucleus accumbens of juvenile mice through the activation of GABA receptors

D. Mishra, K. Chergui

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

761

P.6.b.002 Can behaviour during computer assisted self-infusion of ethanol (CASE) predict the future risk for addiction?

I. Mick, S. O'Connor, V. Vitvitskiy, P. Winiecki, K.F. Mann, U.S. Zimmermann

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

762

P.6.b.003 Effects of acute alcohol consumption on response inhibition of salience attribution

S. Adams, A.F. Ataya, M.R. Munafò

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

763

P.6.b.004 Milnacipran reduces alcohol-induced behaviours, alcohol self-administration and relapse in dependent rats

M. Naassila, E. Simon O'Brien, R. Legastelois, H. Houchi, C. Vilpoux, S. Alaux, O. Pierrefiche, E. André

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

764

P.6.b.005 Alterations of nerve growth factor expression and promoter methylation during alcohol withdrawal

T. Hillemacher, M.A. Muschler, H. Frieling, S. Bleich, A. Heberlein

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

765

P.6.b.006 The psychosocial factors affecting drinking behaviours in Korean young adults with variant ALDH2 genotype

S. Kim, S. Lee, J. Son, C. Shin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

766

P.6.b.007 Alcohol induce selective alterations on opioid system genes regulation in rat amygdala: possible epigenetic mechanisms

C. D'Addario, F.F. Caputi, S. Candeletti, R. Rimondini, P. Romualdi

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

767

P.6.b.008 Cognitive bias in social alcohol consumers: do stimuli matter?

A. Ataya, S. Adams, M.R. Munafò

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

768

P.6.b.009 Alcohol intoxications during adolescence predict later vulnerability to alcohol self-administration in rats

M. Naassila, V. Warnault, M. Kervern, O. Pierrefiche, C. Vilpoux, S. Alaux

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

769

P.6.c.001 Cortisol levels and MDMA-induced memory impairment

K.P.C. Kuypers, J.G. Ramaekers

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

770

P.6.c.002 Impulsivity – an inherited vulnerability marker for stimulant dependence? Preliminary findings

A.J. Turton, S. Pradhan, E.T. Bullmore, T.W. Robbins, K.D. Ersche

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

771

P.6.c.003 Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking

J. Ware, M. Munafò, M. Van Den Bree

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

772

P.6.c.004 Neurocognitive endophenotypes of stimulant dependence – preliminary findings

S. Pradhan, A.J. Turton, T.W. Robbins, E.T. Bullmore, K.D. Ersche

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

773

P.6.c.005 Attentional bias towards cocaine cues using a dot-probe detection task

G. Rubio, J. Chamorro, S. Moratti, I. Martínez-Gras, P. Campo, G. Ponce

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

774

P.6.c.006 Six month follow-up of cocaine users admitted in an outpatient treatment centre in Barcelona (Spain)

C. Castillo, D. Martinez, R. Martinez, P. Rossi, F. Fonseca, M. Astals, G. Mairal, L.L. Tort, M. Torrens

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

775

P.6.c.007 A comparison of methadone-maintained patients with and without co-occuring personality disorder

K. Stoychev, K.M. Ivanov, M.G. Alexandrova, R.D. Stoychev

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

776

P.6.c.008 Respiratory changes following benzodiazepine administration in opioid-dependent human participants

T.M. Williams, R. Lees, R.M. Lovell, G. Henderson, D.J. Nutt, A. Lingford-Hughes

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

777

P.6.c.009 Eplivanserin has no significant abuse potential compared to diazepam and ketamine in recreational drug users

K.A. Schoedel, S. Saubadu, A. Delfolie, J.L. Pinquier, E.M. Sellers

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

778

P.6.c.010 Abuse potential of nabiximols oromucosal spray compared with dronabinol and placebo in recreational marijuana users

K.A. Schoedel, N. Chen, G.W. Guy, S. Wright, A. Patel, L. White, C.G. Stott, E. Russo, E.M. Sellers

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

779

P.6.c.011 A case of unusual severe and prolonged gammabutyrolactone (GBL) withdrawal, treated successfully with valproate

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

780

P.6.d.001 Effect of ORL1 receptor activation on opioid- and psychostimulant-induced conditioned place preference in rats

K. Rutten, J. De Vry, W. Bruckmann, T.M. Tzschentke

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

781

P.6.d.002 Expression of NMDA receptor subunits in human peripheral blood lymphocytes in opioid addiction

R. Roozafzoon, A. Goodarzi, N. Vousooghi, P. Yaghmaei, M. Sedaghati, M.R. Zarrindast

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

782

P.6.d.003 Blockade of amygdalar CRF and dopamine receptors diminishes the reinforcing effects of opiates and opioids

P. Shabanov, A. Lebedev, A. Lyubimov, V. Kornilov

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

783

P.6.d.004 Transient inactivation of nucleus accumbens reduces morphine place preference in rats

H. Sahraei, H. Alieig, M. Ardehari

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

784

P.6.d.005 Evaluation of the role of central adenosine A1 and A2a receptors in the development of tolerance to morphine analgesia in rats

M. Charkhpour, A. Parvizpur, F. Ebrahimi, P. Talebi, H. Samadi, Z. Namjo

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

785

P.6.d.006 Effects of nicotinised and denicotinised cigarette smoking on response to 7.5% carbon dioxide anxiety challenge

A.S. Attwood, J.E. Bailey, D.J. Nutt, A.F. Ataya, M.R. Munafò

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

786

P.6.d.007 Attentional bias to smoking-related cues: a comparison of daily smokers, social smokers and non-smokers

E.L. Mullings, M.R. Munafò

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

787

P.6.d.008 Association between NrCAM gene variants, working memory and cognition in methamphetamine abuse

B. Lee, Y. Kim, D. Kwon, Y. Chung, J. Park, S. Kim, C. Kang, J. Kim, Y. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

788

P.6.d.009 Tobacco and suicidal ideation

M. Vidal Millares, M.C. Armas Barbazán, M.C. García Mahía, P. de Usabel Guzmán, L. Vigo Santamariña, M.J. Mota Rodriguez, A. Pampin Alfonso

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

789

P.6.d.010 Changes in GABAergic expression of habenula and hippocampal formation in mouse administered with amphetamine

L.T. Li, T.W. Tien, Y.H. Yang, H.S. Yin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

790

P.6.d.011 Acute, chronic and withdrawal effects of cocaine on apoptotic signaling in rat brain

M. Alvaro-Bartolomé, J.A. García-Sevilla

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

791

P.6.d.012 Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by cannabinoid withdrawal

A. Aracil, P. Almela, J. Manzanares

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

792

P.6.d.013 Cocaine fails to induce sensitisation to motor responses in transgenic mice overexpressing cannabinoid CB2 receptors

A. Aracil, J. Manzanares

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

793

P.6.d.014 The severity of morphine abstinence correlates with brain FADD phosphorylation: interaction with α2-adrenoceptors

A. Ramos-Miguel, A. Miralles, J.A. García-Sevilla

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

794

P.6.d.015 Altered norepinephrinergic and parvalbumin expression in hippocampal formation of mouse deficient in monoamine oxidase B

H. Yin, T. Tien, J. Wang, J. Shih, K. Chen

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

795

P.6.d.016 Impulsive choice predicts resistance to extinction and vulnerability to reinstatement of cocaine seeking

N. Broos, A.N.M. Schoffelmeer, L. Diergaarde, T. Pattij, T.J. De Vries

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

796

P.6.d.017 Tiagabine prevents changes in alpha(1)-adrenoceptor subtypes induced by cocaine sensitization: immunohistochemical study

J. Kusmierczyk, G. Kreiner, A. Zelek-Molik, M. Kowalska, I. Nalepa

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

797

P.6.d.018 Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus

S. Lecca, A. Luchicchi, S. Carta, M. Melis, A.L. Muntoni, M. Pistis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

798

P.6.d.019 Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area

A. Luchicchi, S. Lecca, S. Carta, M. Pistis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

799

P.6.d.020 Dose-dependent effects of repeated intravenous cocaine on CD4:CD8 lymphocyte ratio in peripheral blood of rats

M.M. Jankowski, B. Ignatowska-Jankowska, W. Glac, A.H. Swiergiel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

800

P.6.d.021 Cannabinoid CB2 receptor antagonist prevents cannabidiol-induced decrease in body weight gains in rats

B. Ignatowska-Jankowska, M.M. Jankowski, W. Glac, A.H. Swiergiel

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

801

P.6.d.022 The role of serotonin and dopamine systems in the action of the psychedelic 4-bromo-2,5-dimethoxyphenylethylamine (2C-B)

T. Palenicek, M. Fujakova, I. Gorman, L. Rambousek, V. Bubenikova-Valesova, J. Horacek

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

802

P.6.d.023 Effects of different schedules of neuroleptic treatment on mesolimbic and nigrostriatal dopaminergic supersensitivity

R. Frussa-Filho, J. Palermo-Neto

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

803

P.6.d.024 Serotonergic challenge of memory functions in MDMA users

K. Preller, N. Dörig, F. Hasler, F.X. Vollenweider, B.B. Quednow

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

804

P.6.d.025 Reduced feed-back related negativity is associated with reinforcement-learning deficits in cocaine dependent patients

M. Kometer, S. Meier, B.B. Quednow, F.X. Vollenweider

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

805

P.6.d.026 Impaired color vision in recreational stimulant users

L. Hulka, M. Wagner, K.U. Kühn, W. Maier, B.B. Quednow

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

806

P.6.d.027 Magnesium as modulator of NMDA receptors in morphine-induced behavioural sensitisation

D. Chelarescu, C. Filip, M. Cuciureanu, O.C. Chelarescu, C. Ghiciuc

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

807

P.6.d.028 Dysfunctional response inhibition correlates with reduced gray matter in the inferior frontal gyrus of cocaine abusers

L. Moreno, E.A. Stamatakis, M.J. Fernández-Serrano, E. Delgado-Rico, M. Pérez-García, A. Verdejo-García

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

808

P.6.e.001 Cognitive flexibility in pathological gambling and alcohol dependence: an fMRI study

R.J. van Holst, A.E. Goudriaan, D.J. Veltman, W. van den Brink

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

809

P.6.e.002 The effect of abstinence from internet video games on working memory in students with excessive internet game playing

C. Na, S.M. Kim, D.H. Han, D.H. Noh, Y.S. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

810

P.6.e.003 Acute psychotic disorder due to the use of ethnobotanical substances

M. Ladea, M. Lepadat, M. Bran, M.C. Sarpe

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

811

P.6.e.004 The effect of smoking cessation on trait anger and personality trait in schizophrenia

H. Lee, S. Hahn, B. Ham, J. Paik, M. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

812

P.6.e.005 Suicide and dual diagnosis

R. Martinez, G. Mateu, L. Díaz, L. Morro, R. Rodríguez, D. Martínez, A. Merino, M. Torrens

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

813

P.6.e.006 Cue reactivity in pathological gamblers and smokers: an fMRI study of behavioural and substance related addictions

A.E. Goudriaan, M.B. de Ruiter, J. Oosterlaan, W. van den Brink, D.J. Veltman

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

814

P.6.f.001 Diminished error processing in smokers during smoking cue exposure: an ERP study

M. Luijten, I.H.A. Franken

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

815

P.6.f.002 Hypericum perforatum, nicotine patches and combination hypericum perforatum/nicotine patches for smoking cessation

M. Kras, C. Stough, A. Scholey, C. Kure, D. Camfield

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

816

P.6.f.003 Repeated administration of modafinil induces behavioural sensitisation in mice

K. Slais, A. Machalova, D. Vrskova, A. Sulcova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

817

P.6.f.004 Effect of toluene chronic inhalation on the process of learning in adult and adolescent rats

M. Zhvania, T.Z. Bikashvili, N.J. Japaridze, L. Gelazonia, L. Chilachava, V. Okuneva

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

818

P.7.a.001 Clinical characteristics of bipolar disorder in children and adolescents in Egypt

M. Abd El-hay, A. Badawy, H. El Sawy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

819

P.7.a.002 A controlled family study of children with DSM-IV bipolar-I disorder

J. Biederman, J. Wozniak, S. Faraone, E. Mick

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

820

P.7.a.003 The long term course of pediatric bipolar disorder: a five year longitudinal follow up study

J. Biederman, J. Wozniak

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 57 KB

english, 2010

821

P.7.a.004 Psychiatric outcomes of girls with ADHD grown up: a controlled 11-year follow-up study

J. Biederman, C. Petty, M. Monuteaux, S. Faraone

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

822

P.7.a.005 Antipsychotic metabolic effects in bipolar youth: comparison with other psychotic and non-psychotic diagnoses

M. Rapado-Castro, C. Moreno, J. Merchan-Naranjo, M. Álvarez, I. Baeza, J.A. Alda, C. Martínez-Cantarero, B. Sánchez, E. de la Serna, C. Arango

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

823

P.7.a.006 Impairment of concept formation ability in children with ADHD: comparisons between lower grades and higher grades

J.S. Kim, H.M. Sung, J.B. Lee, K.H. Lee, J.K. Sakong

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

824

P.7.a.007 Intelligence and neurocognitive functioning by Korean Personality Inventory for Children (KPI-C), profile type in children with ADHD

J.S. Kim, B.H. Koo, J.K. Sakong, S.H. Song

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

825

P.7.a.008 Treatment compliance in children and adolescents initiated on ADHD medication in clinical practice (COMPLY)

P. Wehmeier, D. Quail, R.W. Dittmann, T. Banaschewski

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

826

P.7.a.009 Different levels of salivary steroids in autistic and healthy children

M.D. Majewska, M. Hill, E. Urbanowicz, P. Rok-Bojko, I. Namyslowska, P. Mierzejewski

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

827

P.7.a.010 Comorbidity in patients with attention deficit hyperactivity disorder in psychiatric population in prison

O. Sanz-Garcia, R.M. Dueñas, V. Burges, A. Muro, F. Perez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

828

P.7.a.011 Childhood ADHD in Europe: a comparison of patient and physician profiles across countries

R. Sasane, D. Mitra, P. Hodgkins, K.L. Davis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

829

P.7.a.012 Dyskinesia in naïve children and adolescents treated with olanzapine, risperidone and quetiapine: three months follow up

J. Merchán-Naranjo, M. García-Amador, M. Leiva-Resino, C. Llorente, C. Tapia-Casellas, M. Giráldez, D. Fraguas, C. Arango

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

830

P.7.a.013 Interest of a mobile emergency response team in adolescents' mental health

G. Shadili, E. Dauly, G. Noël

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

831

P.7.b.001 Influence of psychopathology and neurocognitive function on behavioural symptoms in children with ADHD

J.S. Kim, H.M. Sung, J.B. Lee, K.H. Lee, S.K. Sakong

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

832

P.7.b.002 “Quod me nutrit, me destruit” – the pro-anorexia phenomenon: research on the Polish pro-ana virtual community

M. Stochel, W. Losiak, M. Janas-Kozik

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

833

P.7.b.003 Association study of the serotonin 1A receptor gene and tryptophan hydroxylase 2 gene in ADHD

Y. Kwon, S. Shim, H. Jung

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

834

P.7.b.004 Association between dopamine receptor D4 gene polymorphism and drug response in Tourette syndrome

K. Lee, K.C. Paik, M.H. Lim

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

835

P.7.c.001 Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses

M. Hrdlicka, I. Zedkova, M. Blatny, T. Urbanek

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

836

P.7.c.002 Efficacy of risperidone on the core symptoms of autistic disorder

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 41 KB

english, 2010

837

P.7.c.003 One-year follow up of change in functioning in naïve ADHD patients treated with atomoxetine or other standard treatment

R. Escobar, D. Quail, K. De Bruyckere, M. Casillas, P. Berquin, K. Puvanendran, J. Fuentes

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

838

P.7.c.004 Changes in parental depressive mood and quality of life following treatment of ADHD children

J. Hwang, Y. Kim, B. Kim, B. Kim, S. Cho

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

839

P.7.c.005 How do we treat patients with undiagnosed attention deficit hyperactivity disorder? Psychiatric population study in prison

O. Sanz-Garcia, R.m. Dueñas, N. Domenech, R. Ramón, A. Muro, F. Perez

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

840

P.7.c.006 Issues and opportunities in cognitive psychopharmacology trials in children

K.A. Wesnes, H. Brooker

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

841

P.7.c.007 Self-injury among Croatian adolescents: important risk factors

K. Dodig-Curkovic, M. Curkovic, D. Degmecic, P. Filakovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

842

P.7.c.008 The effect of prolonged-release methylphenidate on the sleep of children with attention-deficit/hyperactivity disorders

I. Chung, C.H. Han, H.W. Kim, S.C. Cho

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

843

P.7.c.009 Management of ADHD among children in Europe: a comparison of practice patterns across countries

D. Mitra, R. Sasane, P. Hodgkins, K.L. Davis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

844

P.7.c.010 The cost effectiveness of aripiprazole for the treatment of adolescents with schizophrenia

L. Pericleous, E. Dudley, M. Lebmeier, A. Bentley, R. McAllister

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

845

P.7.c.011 Efficacy of antiepileptic drugs in children and adolescents with cerebral palsy

P. Ignjatovic, N. Jovic

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

846

P.7.d.001 Cognitive and clinical responses among first episode and chronic schizophrenic patients before and after L'Aquila earthquake

R. Pollice, V. Bianchini, L. Verni, M. Mazza, R. Roncone, M. Casacchia

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

847

P.7.d.002 Psychopathology, quality of life, and parental help-seeking behaviours in Korean children with short stature

J. Hwang, B. Lee, J. Seo, S. Lee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

848

P.7.d.003 A clinical usefulness of Korean version of strengths and difficulties questionnaire (SDQ-Kr)

J. Ahn, S. Park, J. Shin

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

849

P.7.e.001 Characteristics of executive function in children with combined type of attention deficit hyperactivity disorder

E.J. Kim, K.W. Yun

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

850

P.7.e.002 European professionals' attitudes and practices in the management of ADHD

M. Fitzgerald, F. McNicholas, L. Henson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

851

P.8.a.001 Dynamics of psycho-vegetative disorders and oncomarkers in chemo-radiotherapy cancer patients exposed to blue light

G. Markarov, S. Shvarkov, J. Fedotova

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

852

P.8.a.002 A one-year follow-up study on suicide attempters: profile of persons who committed suicide

F. Vasquez, Y. Nicolas, S. Falconí, V. Vite

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

853

P.8.a.003 Polypharmacy among psychiatric outpatients in Kuwait

S. Eid, N. Alsafar, S. Alqatan, H. Metwalle

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

854

P.8.a.004 Bridge the gap between primary and psychiatric secondary care

A. Shoka, H. Armson

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 63 KB

english, 2010

855

P.8.a.005 Diagnosis of mental illness by psychiatrists through paintings

C. Rochegude, R. Schwan

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 46 KB

english, 2010

856

P.8.a.006 CSF 3-methoxy-4-hydroxyphenylglycol (MHPG) and dexamethasone test as predictors of suicide risk

J. Jokinen, J. Ouda, P. Nordström

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 62 KB

english, 2010

857

P.8.a.007 Examining patient validity for clinical trials: a post-hoc analysis of placebo responders

L. Brownstein, H. Hassman, S. Haley

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

858

P.8.a.008 Agressivity management in mobile emergency unit

P. Alvaro, A. Martínez, M. Nascimento, D. Córcoles, A. Malagón, F. Portillo, J. Ginés, M. Bellsolà, L.M. Martín, A. Bulbena

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

859

P.8.a.009 Hospitalisation of immigrant patients in a psychiatric sector of a Greek general hospital

M. Anagnostopoulou, A. Karkanias, A. Tselebis, A. Christodoulaki, A. Karakostas, D. Bratis, G. Moussas

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 45 KB

english, 2010

860

P.8.a.010 Coercion in psychiatric care: can paternalism justify coercion?

H. Lee, S. Kim, M. Seo, M. Rhee

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 61 KB

english, 2010

861

P.8.a.011 Psychiatric symptoms among end stage renal disease patients: prevalence and risk factors

D. Radwan, K. Abou Seif, D. Sany, A. Ayed

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

862

P.8.a.012 25-hydroxyvitamin D blood levels in recently admitted psychiatric inpatients

J.J. Mast, K.M. Koorengevel, N.J. van Beveren

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 53 KB

english, 2010

863

C.01.01 Bipolar depression: managing hard to treat symptoms

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

864

C.01.02 Disease severity and treatment-resistance: unraveling the treatment options in depression

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 40 KB

english, 2010

865

C.01.03 Long-term management of depression: what are the treatment options?

K. Demyttenaere

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

866

C.03.01 The importance of recognising organic causes of psychoses

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

867

C.03.03 Clinical picture of an organic psychosis: Niemann-Pick type C

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

868

C.03.04 Changing the disease course: disease-modifying treatment for Niemann-Pick type C

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

869

C.04.01 Treatments for generalised anxiety disorder: mechanism of action and clinical effect

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 44 KB

english, 2010

870

C.04.02 The comorbidity of generalised anxiety disorder and depression: conceptualisation and options for therapy

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 60 KB

english, 2010

871

C.05.01 Schizophrenia: positive and negative symptom relief

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

872

C.05.02 The patient journey: acute mania through to remission

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

873

C.05.03 Treating the symptoms: what matters to the patient?

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

874

C.07.01 Innovative antidepressant treatment targets

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

875

C.07.02 Pharmacogenetics of antidepressants

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

876

C.07.03 Clock genes at the heart of depression

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 43 KB

english, 2010

877

C.08.01 Addressing the adherence challenge in psychosis

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

878

C.08.03 Optimal outcomes for patients with schizophrenia: a focus on functioning

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

879

C.08.04 Moving beyond efficacy in schizophrenia: what do current antipsychotics offer our patients with schizophrenia?

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 39 KB

english, 2010

880

C.10.01 Gene–environment interactions – role in depressive and anxiety disorders

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

881

C.10.02 Late-life depression – do we diagnose and treat correctly?

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

882

C.10.03 Major depressive disorder – are there still unsolved questions?

T.E. Schläpfer

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

883

C.11.02 Using pharmacological insights to inform real-life decision making – part 2

A. Fagiolini, W. Pitchot

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

884

C.11.03 The bipolar environment: the need for effective treatment in bipolar disorder

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

885

C.12.0l Restoring circadian rhythms: a new way to successfully manage depression

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

886

C.12.02 Earlier symptom relief means better outcome of depression

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 42 KB

english, 2010

887

C.12.03 Keeping the patient well: a new option to improve remission rate

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 50 KB

english, 2010

888

C.12.04 Clinical experience with agomelatine in depressed patients

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 30 KB

english, 2010

889

Author Index

Journal:

European Neuropsychopharmacology

Year:

2010

File:

PDF, 127 KB

2010

890

Keyword Index

Journal:

European Neuropsychopharmacology

Year:

2010

Language:

english

File:

PDF, 59 KB

english, 2010

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски